Prof. Shivaprakash M Rudramurthy
Designation : Professor
Department : MEDICAL MICROBIOLOGY
mrshivprakash@gmail.com,mr.shivaprakash@pgimer.edu

 
 
 :: Contact Details
  Phone No.    :   7087008162
  Ext No.        :   5162
 :: Educational Qualification
  Graduation :   MBBS from Mysore Medical College in year 1993
  Post Graduation :   MD (Medical Microbiology) from Mysore Medical College in year 1997
  Other Qualification.(1)      :   PhD from Radboud University Netherlands
     
 :: Area of Interest
       Area Of Interest       :
Epidemiology, diagnosis, and management of mucormycosis,aspergillosis, candidiasis and other invasive fungal infections. Specialinterest in resistant, recurrent and relapsed dermatophytosis. Molecular diagnosisand typing of fungi of outbreak potential, Antifungal Resistance, genomicsurveillance of antifungal resistance, host-pathogen interaction, Noveldiagnostic and therapeutic strategies.
     
 :: Research & Projects
      Extramural Projects       :

1.      Unravelling the Pheno-Genotyping linking and distribution dynamics of Trichophyton mentagrophytes among Human and Animals (ICMR)
2.      Unravelling Antifungal Resistance of Dermatophytes and Polymorphism in Host CARD-9 Gene (ICMR)
3.      Epidemiology, metagenomics and mechanism of echinocandin resistance in Candida tropicalis (DST)
4.      Surveillance of antifungal resistance in India and laboratory support in optimising antifungal therapy at ICMR Nodal Coordinating Centre (ICMR)
5.      Risk factors for COVID-associated Mucormycosis in India (ICMR)
6.      Mechanism, evolution and pharmacology of multidrug resistance in the emerging fungal pathogen Candida auris among the Indian cohort of patients (ICMR)
7.      Burden and acquisition of Candida tropicalis bloodstream infections in healthcare settings, and to study the mechanism of echinocandin resistance of this yeast (DST-SERB)
8.      Characterisation of the genome-wide alterations associated with drug resistance in Candida tropicalis (ICMR)
9.      Evaluation of antifungal activity of lipopeptides from a wild-type Bacillus sp. RLID 12.1 in mouse models of invasive candidiasis, cryptococcosis and aspergillosis (DST-SERB)
10.  The role of skin microbiome in pathobiology of Seborrheic dermatitis and Pityriasis versicolor with special emphasis on Malassezia species (DST-SERB)
11.  A multicentric study to evaluate the host and pathogen factors in recurrent dermatophytosis (IAVDVL)
12.  In-vitro antifungal susceptibility of Malassezia species against luliconazole and itraconazole (ALKEM Laboratories)
13.  Multicenter observational study of candidemia case with special reference to candida auris candidemia among ICU patients in India (ICMR)
14.  A multicentre observational study of candidemia SIHAM (India)
15.  Onychomycosis in agricultural workers of north India- east India epidemiological study & molecular characterization of etiological agent (DBT)
      Departmental / P.G.I.
      Projects      		 :

1.      Incidence, surveillance and control of emerging yeasts with special reference to Cyberlindnera jadinii and Wickerhamomyces anomalus in the pediatric intensive care unit of our tertiary care hospital.

2.      Evolution of optimal cut-off value and diagnostic performance of differential time of positivity (DTP) in diagnosis of central venous catheter-related candidemia (CRC).
      Research In
      Progress      		 :

1.   Basic and advanced training for the diagnosis of fungal infections for the staff of advanced regional mycology centres

2.   Understanding immune phenotypes in chronic fungal infections

3.   Host-pathogen interaction in the development of fungal disease

4.  Developing diagnostic assays for early diagnosis of fungal infection.
      Future Plans       :

Bridging clinical mycology with translational science by advancing rapid and point-of-care diagnostics, establishing robust surveillance systems for antifungal resistance, and deepening insights into the host–pathogen interplay in fungal diseases.

Development of novel antifungal therapeutics alongside precision approaches to identify high-risk patients through molecular epidemiology and host genetic profiling.

      Member Of Professional
      Bodies      		 :

Vice-president (International Society for Human and Animal Mycology (ISHAM)

Fellow, National Academy of Medical Sciences (NAMS),

Fellow, European Confederation of Medical Mycology (ECMM),

Member, American Society for Microbiology (ASM),

Member, European society for clinical microbiology and infectious diseases (ESCMID)

 Member, Infectious Diseases Society of America (IDSA)

Member, Working group of International Society for Human and Animal Mycology, Fungal infection study forum (FISF),

Ex-President (Indian Society of Medical Mycologists (ISMM)
     
 :: Publications(In Vancouver Style)

Research articles
1.     Sehgal IS, Choudhary H,Muthu V, Dhooria S, Prasad KT, Rudramurthy SM, Aggarwal AN, Garg M, ChakrabartiA, Agarwal R. Serum Mannose-Binding Lectin Levels in Asthma and Allergic Bronchopulmonary Aspergillosis. Mycopathologia. 2025 Oct;190(5):1-8. 
2.     Khamrai A, Reddy S, Paul S, Saroya A, Verma S, Bhangot D, Rudramurthy SM, Kaur H,Taneja N, Ghosh AK. Direct Identification of Yeasts from Blood Cultures and Body Fluids Using MALDI-TOF MS with Concurrent Antifungal Susceptibility Testing. Mycopathologia. 2025 Oct;190(5):1-3.
3.     KaurH, Roy M, Jamir I, Yadav S, Gupta A, Ghosh A, Angrup A, Rudramurthy SM.Prospective study on combined use of Sabouraud dextrose agar and blood agar for improved recovery of etiological agents in mycotic and Pythium keratitis.Journal of Microbiological Methods. 2025 Sep 5:107247.
4.     KaurH, Roy M, Jamir I, Yadav S, Gupta A, Ghosh A, Angrup A, Rudramurthy SM.Prospective study on combined use of Sabouraud dextrose agar and blood agar for improved recovery of etiological agents in mycotic and Pythium keratitis.Journal of Microbiological Methods. 2025 Sep 5:107247.
5.     GargM, Bhatia H, Sehgal I, Devkota S, Prabhakar N, Debi U, Kumar R, Rudramurthy SM,Muthu V, Agarwal R. The Conundrum of Computed Tomography Findings in Chronic Pulmonary Aspergillosis: Insights From 103 Cases. Journal of Thoracic Imaging.2025 Sep 1;40(5):e0828.
6.     AgarwalR, Muthu V, Sehgal IS, Prasad KT, Dhooria S, Singh M, Garg M, Aggarwal AN,Rudramurthy SM, Chakrabarti A. Cut‐Offs and Diagnostic Performance of IgG Against Recombinant Aspergillus fumigatus Antigens in Differentiating ABPA From Asthma. Mycoses. 2025 Jul;68(7):e70087.
7.     SahR, Muthu V, Kamboj P, Pal A, Rudramurthy SM, Dhooria S, Sehgal IS, Prasad KT,Garg M, Aggarwal AN, Agarwal R. Serum periostin and carcinoembryonic antigen for diagnosing and assessing response in allergic bronchopulmonary aspergillosis. Lung India. 2025 Jul 1;42(4):309-14.
8.     MadduriM, Rudramurthy SM, Roy U. Bacillus-derived Lipopeptides Inhibit and Eradicate Candida tropicalis Biofilms: An in Vitro exploration. Biofilm. 2025 Jun14:100294.
9.     ChauhanA, Carolus H, Sofras D, Kumar M, Kumar P, Nair R, Narayanan A, Yadav K, Ali B,Biriukov V, Saini A. Multi‐Omics Analysis of Experimentally Evolved Candida auris Isolates Reveals Modulation of Sterols, Sphingolipids, and Oxidative Stress in Acquired Amphotericin B Resistance. Molecular microbiology. 2025 Jun4.
10.  Nair SS, Thomas P, Abdel-Glil MY, Prajapati SK, Reddi L,Kumar B, Saikumar G, Dandapat P, Rudramurthy SM. Whole genome sequence analysis of Microsporum canis: A study based on animal strains isolated from India. TheMicrobe. 2025 Jun 1;7:100329.
11.  Agarwal R, Sehgal IS, Muthu V, Dhooria S, Prasad KT,Singh M, Rudramurthy SM, Aggarwal AN, Garg M, Chakrabarti A. Comparative diagnostic performance of mx4-IgE versus species-specific IgE for identifying allergic bronchopulmonary aspergillosis. The Journal of Allergy and Clinical Immunology: In Practice. 2025 May 30.
12.  Kumar K, Choudhary H, Ahmad H, Muthu V, Gupta P,Rudramurthy SM, Agnihotri S, Agarwal R, Chakrabarti A, Kaur H. Diagnostic performance of an in-house real-time polymerase chain reaction (PCR) assay and antigen detection from respiratory samples for the diagnosis of pulmonary cryptococcosis. Diagnostic Microbiology and Infectious Disease. 2025 May22:116924.
13.  Agarwal R, Sehgal IS, Saxena P, Dhooria S, Muthu V,Soundappan K, Prasad KT, Garg M, Rudramurthy SM, Aggarwal AN, Chakrabarti A. Adecision tree analysis to evaluate the optimal approach to screen allergic bronchopulmonary aspergillosis in asthmatic patients. Journal of Asthma. 2025May 4;62(5):761-6.
14.  Sharma V, Das S, Spruijtenburg B, de Groot T, Meijer E,Kaur H, Rudramurthy SM, Ghosh A. Genotypic Diversity and Molecular Basis of Fluconazole Resistance in Candida parapsilosis Clinical Isolates Collected Over7 Years in a Tertiary‐Care Hospital in North India. Mycoses. 2025May;68(5):e70062.
15.  Sehgal IS, Muthu V, Dhooria S, Prasad KT, Garg M,Rudramurthy SM, Aggarwal AN, Chakrabarti A, Agarwal R. Impact of bronchiectasis severity on clinical outcomes in patients with allergic bronchopulmonary aspergillosis: A retrospective cohort study. The Journal of Allergy andClinical Immunology: In Practice. 2025 May 1;13(5):1103-9.
16.  Nawaz RS, Agarwal R, Rudramurthy SM, Choudhary H,Harchand R, Kumar K, Sehgal IS, Kaur H, Dhooria S, Prasad KT, Prabhakar N.Sensitivity and Specificity of Plasma and Bronchoalveolar Lavage Fluid PCR for Diagnosing Pulmonary Mucormycosis in Subjects With Diabetes Mellitus. Mycoses.2025 Apr;68(4):e70063.
17.  Kiran K, Rudresh SM, Raksha Y, Ragunatha S, Jyoti G,Shivaprakash MR. Molecular identification of Malassezia from the skin scrapingsof clinically suspected cases of pityriasis versicolor. Indian Journal ofPathology and Microbiology. 2025 Apr 1;68(2):354-9.
18.  Gahlot P, Hallur V, Behera B, Purushotham P, Paul D,Pillai J, Tripathy S, Dey A, Gulla KM, Das M, Rudramurthy SM. Navigating the molecular landscape of Candida auris in a tertiary care setting in Eastern India. Indian Journal of Medical Microbiology. 2025 Mar 1;54:100814.
19.  Thakur S, Spruijtenburg B, Abhishek, de Groot T, MeijerEF, Narang T, Dogra S, Walia K, Chakrabarti A, Meis JF, Rudramurthy SM.Amplified fragment length polymorphism genotyping of Trichophyton indotineae indicates possible zoonotic transmission. Medical Mycology. 2025Mar;63(3):myaf020.
20.  Arya K, Usmani SA, Chandra S, Chaturvedi S, Ali B, Kumar M, Bhardwaj N, Kumar M, Gaur NA, Rudramurthy SM, Prasad R. Diversity in the lipidomes of Trichophyton rubrum, Trichophyton interdigitale and Trichophyton tonsurans, and their phenotypes. Microbial Pathogenesis. 2025 Mar 1;200:107362.
21.  Sehgal IS, Arora K, Agarwal R, Kumar R, Rana N, DhooriaS, Muthu V, Prasad KT, Garg M, Rudramurthy SM, Aggarwal AN. Serial Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (18FDG-PET-CT)in Assessing Treatment Response in Chronic Pulmonary Aspergillosis. The Journalof Infectious Diseases. 2025 Feb 15;231(2):532-9.
22.  Thakur S, Spruijtenburg B, Abhishek, Shaw D, de Groot T,Meijer EF, Narang T, Dogra S, Chakrabarti A, Meis JF, Rudramurthy SM. Whole genome sequence analysis of terbinafine resistant and susceptible Trichophyton isolates from human and animal origin. Mycopathologia. 2025 Feb;190(1):13.
23.  Sehgal IS, Soundappan K, Muthu V, Dhooria S, Prasad KT,Rudramurthy SM, Aggarwal AN, Raju R, Garg M, Prabhakar N, Chakrabarti A.Performance of LDBio Aspergillus ICT IgM/IgG lateral flow assay in diagnosing chronic pulmonary aspergillosis in community versus hospital setting.Mycopathologia. 2025 Feb;190(1):9.
24.  Kumar P, Ali B, Kumar M, Carolus H, Romero CL, Vergauwen R, Chauhan A, Narayanan A, Banerjee A, Gaur NA, Singh A. The experimentally evolved fluconazole-resistant clade II isolates of Candidozyma auris exhibit adistinct lipid compositional landscape, highlighting intraclade sphingolipid heterogeneity. FEMS Yeast Research. 2025;25:foaf030.
25.  Paul RA, Madduri M, Kashyap N, Ramesh S, Rudramurthy SM,Roy U. Efficacy of two novel antifungal lipopeptides, AF4 and AF5 of bacillomycin D family in murine models of invasive candidiasis, cryptococcosis,and aspergillosis. APMIS. 2025 Jan;133(1):e13506.
26.  Sahni N, Biswal M, Yaddanapudi L, Ray P, Taneja N, MR Shivaprakash,Saini V, Mathur P, Walia K. 1273: PROSPECTIVE SURVEILLANCE STUDY OF CLABSI ANDVAP IN ICU OF TERTIARY ACADEMIC HOSPITAL IN NORTH INDIA. Critical CareMedicine. 2025 Jan 1;53(1).
27.  Paul RA, Madduri M, Kashyap N, Ramesh S, Rudramurthy SM,Roy U. Efficacy of two novel antifungal lipopeptides, AF4 and AF5 of bacillomycin D family in murine models of invasive candidiasis, cryptococcosis,and aspergillosis. APMIS. 2025 Jan;133(1):e13506.
28.  Agarwal R, Muthu V, Sehgal IS, Prasad KT, Dhooria S, GargM, Aggarwal AN, Rudramurthy SM, Chakrabarti A. Sex Differences in Allergic Bronchopulmonary Aspergillosis and its Impact on Exacerbations. Mycopathologia.2024 Dec;189(6):90.
29.  Kaur H, Jamir I, Yangzes S, et al. Papulaspora equikeratitis in an infant. Indian J Med Microbiol. 2024;52:100748.doi:10.1016/j.ijmmb.2024.100748
30.  Sehgal IS, Saxena P, Dhooria S, Muthu V, Kathirvel S,Prasad KT, Garg M, Rudramurthy SM, Aggarwal AN, Chakrabarti A, Agarwal R. Isthe prevalence of allergic bronchopulmonary aspergillosis greater in severe asthma?. The Journal of Allergy and Clinical Immunology: In Practice. 2024 Dec1;12(12):3269-73.
31.  Sehgal IS, Dhooria S, Muthu V, et al. The minimal important difference of one-minute-sit-to-stand test in subjects with chronic pulmonary aspergillosis. Lung India. 2024;41(5):353-356.doi:10.4103/lungindia.lungindia-168-24
32.  Muthu V, Kumar R, Prasad KT, Sehgal IS, Dhooria S,Soundappan K, Rudramurthy SM, Chakrabarti A, Aggarwal AN, Agarwal R.Aspergillus sensitization in non-smokers versus smokers with chronic obstructive pulmonary disease. Lung India. 2024 Sep 1;41(5):387-91.
33.  Ali B, Kumar M, Kumar P, Chauhan A, Usmani SA,Rudramurthy SM, Meis JF, Chakrabarti A, Singh A, Gaur NA, Mondal AK.Sphingolipid diversity in Candida auris: unraveling interclade and drug resistance fingerprints. FEMS Yeast Research. 2024;24:foae008.
34.  Shastri M, Srinivasan R, Kundu R, Dey P, Gupta N, Gupta P, Rohilla M, Kang M, Kalra N, Kaur H, Rudramurthy SM. Mucormycosis:Cytomorphological Spectrum in Fine-Needle Aspiration Cytology. Journal of Cytology. 2024 Jan 1;41(1):47-52.
35.  Jain S, Mohindra R, Chatterjee D, Rudramurthy S, Vyas S,Dogra S, Narang T. Leprosy, steroids, and diabetes: a recipe for mucormycosis?.International Journal of Dermatology. 2024 Jan 1;63(1).
36.  Ramesh S, Roy U, Roy S, Rudramurthy SM. A promising antifungal lipopeptide from Bacillus subtilis: its characterization and insight into the mode of action. Applied Microbiology and Biotechnology. 2024Dec;108(1):161.
37.  Sharma K, Angrup A, Ghosh A, Singh S, Sood A, Arora A,Sharma M, Sethi S, Rudramurthy SM, Kaur H, Ray P. Evaluation of VITEK MS Version 3.0 MALDI-TOF for the identification of anaerobes, mycobacteria,Nocardia, and moulds. Diagnostic Microbiology and Infectious Disease. 2024 Dec1;110(4):116477.
38.  Soundappan K, Muthu V, Dhooria S, Sehgal IS, Prasad KT,Rudramurthy SM, Chakrabarti A, Aggarwal AN, Agarwal R. Population prevalence ofaspergillus sensitization and allergic bronchopulmonary aspergillosis in COPD subjects in North India. Mycoses. 2024 Aug;67(8):e13784.
39.  Shaw D, Dogra S, Singh S, Shah S, Narang T, Kaur H, WaliaK, Ghosh A, Handa S, Chakrabarti A, Rudramurthy SM. Prolonged treatment of dermatophytosis caused by Trichophyton indotinea with terbinafine or itraconazole impacts better outcomes irrespective of mutation in the squalene epoxidase gene. Mycoses. 2024 Aug;67(8):e13778.
40.  Bhardwaj N, Aggarwal A, Kaur H, Rudramurthy SM, Gupta K.Cerebellar phaeohyphomycosis: a dark enigma. Clinical Microbiology and Infection. 2024 Aug 1;30(8):1018-9.
41.  Kaur H, Gupta P, Ahmad H, Shankarnarayan SA, Salunke P,Bansal D, Shah A, Tarai B, Patel K, Singla N, Samaddar A. Clinical spectrum,phenotypic and molecular characterization, and antifungal susceptibility of an emerging human pathogen, Acrophialophora, from India. Medical Mycology. 2024Jul;62(7):myae061.
42.  Kaur H, Kanaujia R, Nayak G, Ramavat AS, Patro S, GhoshA, Chakrabarti A, Rudramurthy SM. An interesting report of COVID-19 associated mucormycosis (CAM) cases by two different species of Mucorales. Indian Journalof Medical Microbiology. 2024 Jul 1;50:100656.
43.  Das S, Singh S, Tawde Y, Dutta TK, Rudramurthy SM, KaurH, Shaw T, Ghosh A. Comparative fitness trade-offs associated with azole resistance in Candida auris clinical isolates. Heliyon. 2024 Jun 30;10(12).
44.  Khamrai A, Paul S, Rudramurthy SM, Ghosh AK. Carbon substrates promotes stress resistance and drug tolerance in clinical isolates of Candida tropicalis. Archives of Microbiology. 2024 Jun;206(6):270.
45.  Gupta S, Srivastava A, Vyas N, Kaur H, Sharma BS,Rudramurthy SM. Fungal thalamic abscess caused by Rhinocladiella mackenziei in an immunocompetent patient. Indian Journal of Medical Microbiology. 2024 May1;49:100605.
46.  Chirumamilla NK, Arora K, Kaur M, Agarwal R, Muthu V,Rawat A, Dhooria S, Prasad KT, Aggarwal AN, Rudramurthy SM, Chakrabarti A.Innate and adaptive immune responses in subjects with CPA secondary to post‐pulmonary tuberculosis lung abnormalities. Mycoses. 2024 May;67(5):e13746.
47.  Muthu V, Agarwal R, Rudramurthy SM, Thangaraju D,Shevkani MR, Patel AK, Shastri PS, Tayade A, Bhandari S, Gella V, Savio J.Prevalence of co‐existent COVID‐19‐associated pulmonary aspergillosis (CAPA)and its impact on early mortality in patients with COVID‐19‐associate pulmonary mucormycosis (CAPM). Mycoses. 2024 May;67(5):e13745.
48.  Honnavar P, Chakrabarti A, Joseph J, Thakur S, Dogra S,Lakshmi PV, Rudramurthy SM. Molecular epidemiology of seborrheic dermatitis/dandruff associated Malassezia species from northern India. MedicalMycology. 2024 Oct;62(10):myae104.
49.  Choudhary H, Kaur H, Singh S, Singh R, Muthu V, Verma R,Rudramurthy SM, Agarwal R, Jain S, Bal A, Ghosh AK. A novel indirect ELISA for serodiagnosis of mucormycosis using antigens from Rhizopus arrhizus. Mycoses.2024 May;67(5):e13730.
50.  Kanaujia R, Arora A, Chakrabarti A, Rudramurthy SM,Agarwal R. Polymorphisms in innate and adaptive immune genes in subjects withallergic bronchopulmonary aspergillosis complicating asthma. Mycopathologia.2024 Apr;189(2):23.
51.  Soundappan K, Sehgal IS, Prabhakar N, Rana S, Raju R,Dhooria S, Prasad KT, Muthu V, Rudramurthy SM, Chakrabarti A, Garg M. Incidenceand prevalence of chronic pulmonary aspergillosis in patients withpost‐tuberculosis lung abnormality: results from a community survey in NorthIndia. Mycoses. 2024 Mar;67(3):e13711.
52.  Muthu V, Agarwal R, Rudramurthy SM, Thangaraju D,Shevkani MR, Patel AK, Shastri PS, Tayade A, Bhandari S, Gella V, Savio J. Risk factors, mortality, and predictors of survival in COVID-19-associated pulmonary mucormycosis: a multicentre retrospective study from India. Clinical Microbiology and Infection. 2024 Mar 1;30(3):368-74.
53.  Sehgal IS, Muthu V, Dhooria S, Prasad KT, Rudramurthy SM,Aggarwal AN, Garg M, Gangneux JP, Chakrabarti A, Agarwal R. Sensitivity and specificity of LDBio Aspergillus ICT lateral flow assay for diagnosing allergic bronchopulmonary aspergillosis in adult asthmatics. Mycoses. 2024 Feb;67(2):e13700.
54.  Madhuri M, Rudramurthy SM, Roy U. Two promising Bacillus-derived antifungal lipopeptide leads AF4 and AF5 and their combined effect with fluconazole on the in vitro Candida glabrata biofilms. Frontiers in pharmacology. 2024 Apr 19;15:1334419.
55.  Damaraju V, Agarwal R, Prabhakar N, Bal A, RudramurthySM, Muthu V. Isolated tracheal mucormycosis in diabetes mellitus and bronchoscopic management. Lung India. 2024 May 1;41(3):226-7.
56.  Muthu V, Agarwal R, Rudramurthy SM, Thangaraju D,Shevkani MR, Patel AK, Shastri PS, Tayade A, Bhandari S, Gella V, Savio J.Computed tomography findings of COVID-19-associated pulmonary mucormycosis:Data from a multicenter retrospective study (Mucovi2), India. Lung India. 2024May 1;41(3):221-4.
57.  Madduri M, Rudramurthy SM, Roy U. Two promising natural lipopeptides from Bacillus subtilis effectively induced membrane permeabilization in Candida glabrata. Acta Biochimica Polonica. 2024 Jan31;71:11999.
58.  Agarwal R, Sehgal IS, Muthu V, Denning DW, Chakrabarti A,Soundappan K, Garg M, Rudramurthy SM, Dhooria S, Armstrong-James D, Asano K.Revised clinical practice guidelines for diagnosing, classifying, and treating allergic bronchopulmonary aspergillosis/mycoses: a Delphi statement from the ISHAM-ABPA working group. European Respiratory Journal. 2024 Feb 29.
59.  Rudramurthy SM, Muthu V, Agarwal R. Contemporary diagnosis and epidemiological trends of mucormycosis: A call for action andcaution. The Lancet Regional Health–Europe. 2024 Oct 1;45.
60.  Dhaliwal M, Muthu V, Sharma A, Raj K, Rudramurthy SM, AgarwalR, Kaur H, Rawat A, Singh S, Chakrabarti A. Immune and metabolic perturbationsin COVID‐19‐associated pulmonary mucormycosis: A transcriptome analysis of innate immune cells. Mycoses. 2024 Jan;67(1):e13679.
61.  Jain P, Rudramurthy S, Patil N, Dethe G, Patil A, JessaniL. Fusarium infection on the penile prepuce in an allogeneic transplant recipient. Indian Journal of Hematology and Blood Transfusion. 2024Jul;40(3):547-8.
62.  Arya K, Usmani SA, Bhardwaj N, Kumar M, Rudramurthy SM,Prasad R, Singh A. Impact of sphingolipid synthesis inhibition on the drug susceptibility patterns of Trichophyton species. Diagnostic microbiology and infectious disease. 2024 Jun 1;109(2):116283.
63.  Mathur P, Srivastav S, Thakur AK, Parveen R, Puraswani M,Srivastava AK, Chakrabarti A, Rodrigues C, Balaji V, Ray P, Biswal M.Candidaemia and Central Line‐Associated Candidaemia in a Network of Indian ICUs: Impact of COVID‐19 Pandemic. Mycoses. 2024 Sep;67(9):e13790.
64.  Sehgal IS, Dhooria S, Muthu V, Prasad KT, Aggarwal AN,Chakrabarti A, Rudramurthy SM, Agarwal R. The minimal important difference of Saint George’s Respiratory Questionnaire in subjects with chronic pulmonary aspergillosis. Medical Mycology. 2023 May;61(5):myad048.
65.  Agarwal R, Sehgal IS, Muthu V, Dhooria S, Prasad KT,Aggarwal AN, Garg M, Rudramurthy SM, Chakrabarti A. Long‐term follow‐up of allergic bronchopulmonary aspergillosis treated with glucocorticoids: A studyof 182 subjects. Mycoses. 2023 Nov;66(11):953-9.
66.  Sehgal IS, Dhooria S, Rudramurthy SM, Prasad KT, Muthu V,Aggarwal AN, Garg M, Rastogi P, Agarwal R. Role of C-reactive protein and erythrocyte sedimentation rate in the diagnosis and monitoring of treatment response in treatment naive subjects with chronic pulmonary aspergillosis.Mycopathologia. 2023 Oct;188(5):705-11.
67.  Satija A, Anand T, Mukherjee A, Velamuri PS, Singh KJ,Das M, Josten K, Keche AY, Nagarkar NM, Gupta P, Himanshu D. Satellite epidemic of Covid-19 associated mucormycosis in India: A multi-site observational study.Mycopathologia. 2023 Oct;188(5):745-53.
68.  Sehgal IS, Arora K, Cornely OA, Salzer HJ, Dhooria S,Prasad KT, Garg M, Rudramurthy SM, Muthu V, Aggarwal AN, Chakrabarti A.Characterization of treatment response outcomes in chronic pulmonary aspergillosis: CPAnet definitions versus the existing criteria. Mycopathologia.2023 Oct;188(5):721-30.
69.  Borgohain P, Barua P, Shaw D, Saikia LR, Mahanta J,Rudramurthy SM. Onychomycosis caused by dematiaceous fungi: A four-year studyon agricultural workers of Assam, India. Current Medical Mycology. 2023 Sep;9(3):8.
70.  Tawde Y, Das S, Gupta A, Sharma S, Basak S, Shrimali T,Singh S, Rudramurthy SM, Kaur H, Ghosh A. Development of single‐tube real‐timePCR assay for the rapid detection of Aspergillus and Fusarium—The two mostcommon causative agents in fungal keratitis. Mycoses. 2023 Sep;66(9):801-9.
71.  Parashar A, Rastogi V, Prakash H, Pandey A, RudramurthySM. Intergenic spacer (IGS-1) region sequence-based identification, genotypic analysis, and antifungal susceptibility of clinical Trichosporon species.Indian Journal of Medical Microbiology. 2023 Sep 1;45:100390.
72.  Muthu V, Gogineni RR, Agarwal R, Prasad KT, Sehgal IS,Dhooria S, Aggarwal AN, Rudramurthy SM, Singh H, Garg M, Chakrabarti A.Treatment of pulmonary mucormycosis with adjunctive nebulized amphotericin B (MUCONABtrial): results of an open‐label randomized controlled trial. Mycoses. 2023Aug;66(8):688-96.
73.  Rudramurthy SM, Singh S, Kanaujia R, Chaudhary H, MuthuV, Panda N, Pandey A, Thakur S, Kaur H, Ghosh A, Agarwal R. Clinical and mycologic characteristics of emerging mucormycosis agent Rhizopus homothallicus. Emerging Infectious Diseases. 2023 Jul;29(7):1313.
74.  Sehgal IS, Vinay K, Dhooria S, Muthu V, Prasad KT, Aggarwal AN, Chakrabarti A, Rudramurthy SM, Choudhary H, Agarwal R. Efficacy of generic forms of itraconazole capsule in treating subjects with chronicpulmonary aspergillosis. Mycoses. 2023 Jul;66(7):576-84.
75.  Soundappan K, Muthu V, Dhooria S, Sehgal IS, Prasad KT,Rudramurthy SM, Chakrabarti A, Aggarwal AN, Agarwal R. Population prevalence of allergic bronchopulmonary aspergillosis in asthma: An epidemiological study of 43,261 participants from North India. Clinical & Experimental Allergy. 2023Jul 1;53(7).
76.  Spruijtenburg B, Rudramurthy SM, Meijer EF, van Haren MH , Kaur H, Chakrabarti A, Meis JF, de Groot T. Application of novel short tandem repeat typing for Wickerhamomyces anomalus reveals simultaneous outbreaks within a single hospital. Microorganisms. 2023 Jun 8;11(6):1525.
77.  Rudramurthy SM, Shaw D, Shankarnarayan SA, Abhishek,Dogra S. Comprehensive taxonomical analysis of Trichophyton mentagrophytes/interdigitale complex of human and animal origin from India.Journal of Fungi. 2023 May 16;9(5):577.
78.  Aaghaz S, Sharma K, Maurya IK, Rudramurthy SM, Singh S,Kumar V, Tikoo K, Jain R. Synthetic amino acids‐based short amphipathic peptides exhibit antifungal activity by targeting cell membrane disruption.Drug Development Research. 2023 May;84(3):514-26.
79.  Kaur H, Gupta P, Pilania R, Suri D, Singh S, Ghosh A,Rudramurthy SM. Trend of pediatric cryptococcosis in a tertiary care centre and review of literature. Indian Journal of Medical Microbiology. 2023 May1;43:18-29
80.  Kaur H, Kanaujia R, Singh S, Kajal K, Jayashree M, PeterNJ, Verma S, Gupta M, Ray P, Ghosh A, Samujh R. Clinical utility of time to positivity of blood cultures in cases of fungaemia: a prospective study. IndianJournal of Medical Microbiology. 2023 May 1;43:85-9.
81.  Sehgal IS, Dhooria S, Sachdeva N, Rudramurthy SM, PrasadKT, Muthu V, Aggarwal AN, Garg M, Chakrabarti A, Agarwal R. Role of serum procalcitonin in the diagnosis and monitoring of treatment response in treatment-naïve subjects with chronic pulmonary aspergillosis. Heliyon. 2023Apr 1;9(4).
82.  Aaghaz S, Sharma K, Maurya IK, Rudramurthy SM, Singh S,Kumar V, Tikoo K, Jain R. Anticryptococcal activity and mechanistic studies ofshort amphipathic peptides. Archiv der Pharmazie. 2023 Apr;356(4):2200576.
83.  Sehgal IS, Dhooria S, Muthu V, Rudramurthy SM, Prasad KT,Chakrabarti A, Aggarwal AN, Agarwal R. Identification of distinct immunophenotypes in chronic pulmonary aspergillosis using cluster analysis.Mycoses. 2023 Apr;66(4):299-303.
84.  Gupta P, Kaur H, Rompally S, Muthu V, Kollabathula A,Sharma A, Srivastava S, Rudramurthy SM. Disseminated Cryptococcosis and Pulmonary Mucormycosis: Dealing with Dual Mycoses in a Renal Transplant Patient. Mycopathologia. 2023 Apr;188(1):163-7.
85.  Bhalavi H, Shaw D, Mehta H, Narang T, Sachdeva N, ShafiqN, Rudramurthy SM, Dogra S. Correlation of plasma levels of itraconazole with treatment response at 4 weeks in chronic dermatophytosis: Results of arandomised controlled trial. Mycoses. 2023 Apr;66(4):281-8.
86.  Singh S, Kanaujia R, Agnihotri S, Kaur H, Chakrabarti A,Rudramurthy SM. The comparative evaluation of the fujifilm wako β-glucan assay and fungitell assay for diagnosing invasive fungal disease. Journal of Fungi.2022 Dec 20;9(1):6.
87.  Ramesh S, Madduri M, Rudramurthy SM, Roy U. Functionalcharacterization of a Bacillus-derived novel broad-spectrum antifungal lipopeptide variant against Candida tropicalis and Candida auris and unravelling its mode of action. Microbiology Spectrum. 2023 Apr13;11(2):e01583-22.
88.  Sehgal IS, Dhooria S, Muthu V, Prasad KT, Aggarwal AN,Chakrabarti A, Rudramurthy SM, Agarwal R. The minimal important difference of six-minute walk test in subjects with chronic pulmonary aspergillosis treated with six-months of oral itraconazole. Lung India. 2023 Mar 1;40(2):185-7.
89.  Kaur H, Gupta P, Ahmad H, Shankarnarayan SA, SrivastavaS, Sahu S, Karuna T, Narang T, Gupta S, Ghosh A, Rudramurthy SM. Cladosporium halotolerans: Exploring an Unheeded Human Pathogen. Mycopathologia. 2023Dec;188(6):1027-40.
90.  Sehgal IS, Dhooria S, Soundappan K, Rudramurthy SM,Chakrabarti A, Agarwal R. Comparison of three sample types for performing LDBioAspergillus immunochromatographic technology lateral flow assay for IgG/IgM antibody detection in chronic aspergillosis. Clinical Microbiology and Infection. 2023 Mar 1;29(3):404-5.
91.  Muthu V, Agarwal R, Rudramurthy SM, Thangaraju D,Shevkani MR, Patel AK, Shastri PS, Tayade A, Bhandari S, Gella V, Savio J.Multicenter case–control study of COVID-19–associated mucormycosis outbreak,India. Emerging Infectious Diseases. 2023 Jan;29(1):8.
92.  Kumar M, Thomas P, Nair SS, Bagra JK, Chaturvedi VK,Kumar B, Kumar A, Rudramurthy SM. Molecular epidemiology of Trichophyton infections among canines from Northern India. Journal of Medical Mycology. 2023Mar 1;33(1):101352.
93.  Sharma K, Aaghaz S, Maurya IK, Sharma KK, Singh S,Rudramurthy SM, Kumar V, Tikoo K, Jain R. Synthetic amino acids-derived peptides target Cryptococcus neoformans by inducing cell membrane disruption.Bioorganic Chemistry. 2023 Jan 1;130:106252.
94.  Kanaujia R, Muthu V, Singh S, Rudramurthy SM, Kaur H.Rapidly progressive lung coinfection due to Rhizopus and Scedosporium in adiabetic marijuana smoker. Clinical Microbiology and Infection. 2023 Jan1;29(1):51-3.
95.  Sharma K, Aaghaz S, Maurya IK, Singh S, Rudramurthy SM,Kumar V, Tikoo K, Jain R. Ring-modified histidine-containing cationic short peptides exhibit Anticryptococcal activity by cellular disruption. Molecules.2022 Dec 22;28(1):87.
96.  Aaghaz S, Sharma K, Maurya IK, Rudramurthy SM, Singh S,Kumar V, Tikoo K, Jain R. Anticryptococcal activity and mechanistic investigation of histidine-rich short peptides. Journal of Molecular Structure.2023 Mar 15;1276:134813.
97.  Choudhary D, Kaur H, Subramani VN, Pattanaik S, Patil SS,Sethi J, Kaur M, Sreenivasan P, Thakur S, Gupta P, Sekar A. Scedosporiuminfection in recipients of kidney transplants from deceased near-drowning donor. Emerging infectious diseases. 2023 Nov;29(11):2406.
98.  Narayanan A, Kumar P, Chauhan A, Kumar M, Yadav K,Banerjee A, Sharma RD, Rudramurthy SM, Chakrabarti A, Sanyal K, Prasad R.Directed evolution detects supernumerary centric chromosomes conferring resistance to azoles in Candida auris. MBio. 2022 Dec 20;13(6):e03052-22.
99.  Anand T, Mukherjee A, Satija A, Velamuri PS, Singh KJ,Das M, Josten K, Yadav PD, Sahay RR, Keche AY, Nagarkar NM. A case control investigation of COVID-19 associated mucormycosis in India. BMC InfectiousDiseases. 2022 Nov 16;22(1):856.
100. Sharma M, Rudramurthy SM, Chakrabarti A. Epidemiology of invasive fungal infections insolid organ transplant recipients: an Indian perspective. Current Fungal Infection Reports. 2022 Dec;16(4):179-87.
101.  YadavB, Gupta N, Ahmed H, Gupta P, Chaudhary H, Bansal R, Rudramurthy SM, Kaur H.Mycotic Endophthalmitis by Parathyridaria percutanea. Mycopathologia. 2022Dec;187(5):623-6.
102. KathirvelS, Muthu V, Rudramurthy SM, Kaur H, Chakrabarti A, Agarwal R. Could cattle dung burning have contributed to the epidemic of COVID‐19‐associated mucormycosis in India? Results of an experimental aero‐mycological study. Mycoses. 2022Nov;65(11):1024-9.
103.  KaurH, Krishnamoorthi S, Dhaliwal N, Biswal M, Singh S, Muthu V, Rudramurthy SM,Agarwal R, Ghoshal S, Singh S, Malhotra P. Antifungal prescription practices and consumption in a tertiary care hospital of a developing country. Mycoses.2022 Oct;65(10):935-45.
104.  Sharma K, Aaghaz S, Maurya IK, Rudramurthy SM, Singh S, Kumar V, Tikoo K, Jain R.Antifungal evaluation and mechanistic investigations of membrane active short synthetic peptides-based amphiphiles. Bioorganic Chemistry. 2022 Oct1;127:106002.
105. GhoshAK, Singh R, Reddy S, Singh S, Rudramurthy SM, Kaur H, Choudhary H, ChakrabartiA. Evaluation of environmental Mucorales contamination in and around the residence of COVID-19-associated mucormycosis patients. Frontiers in Cellular and Infection Microbiology. 2022 Sep 2;12:953750.
106. MuthuV, Dhaliwal M, Sharma A, Nair D, Kumar HM, Rudramurthy SM, Sehgal IS, ChoudharyH, Panda N, Chakrabarti A, Agarwal R. Serum glucose-regulated protein 78(GRP78) levels in COVID-19-associated mucormycosis: results of a case–controlstudy. Mycopathologia. 2022 Aug;187(4):355-62.
107.  PaulS, Shaw D, Joshi H, Singh S, Chakrabarti A, Rudramurthy SM, Ghosh AK.Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis. PLoS One. 2022 Jul 12;17(7):e0269721.
108.  ParasharA, Rastogi V, Rudramurthy SM, Ghosh AK, Chander J, Kindo AJ. Faster and accurate identification of clinically important Trichosporon using MALDI TOFMS. Indian Journal of Medical Microbiology. 2022 Jul 1;40(3):359-64.
109.  TawdeY, Singh S, Das S, Rudramurthy SM, Kaur H, Gupta A, Kataki M, Gogoi P, GhoshAK. Clinical and mycological profile of fungal keratitis from North andNorth-East India. Indian Journal of Ophthalmology. 2022 Jun 1;70(6):1990-6.
110. KanaujiaR, Arora A, Chakrabarti A, Rudramurthy SM, Agarwal R. Occurrence of cystic fibrosis transmembrane conductance regulator gene mutations in patients with allergic bronchopulmonary aspergillosis complicating asthma. Mycopathologia.2022 Jun;187(2):147-55.
111.  MuraleedharanM, Panda NK, Angrish P, Arora K, Patro SK, Bansal S, Chakrabarti A, RudramurthySM, Bakshi J, Mohindra S, Gupta R. As the virus sowed, the fungus reaped! Acomparative analysis of the clinico‐epidemiological characteristics of rhino‐orbital mucormycosis before and during COVID‐19 pandemic. Mycoses. 2022May;65(5):567-76.
112. KanaujiaR, Ramanathan S, Sarode R, Kanaujia R, Rudramurthy SM, Gupta S. Budding yeastin a child with acute leukemia: Nothing CRYPT (O) IC about it. Indian Journal of Pathology and Microbiology. 2022 Apr 1;65(2):468-71.
113. SinghS, Choudhary H, Agnihotri S, Sehgal IS, Agarwal R, Kaur H, Ghosh A, ChakrabartiA, Rudramurthy SM. LDBio Aspergillus immunochromatographic test lateral flowassay for IgG/IgM antibody detection in chronic pulmonary aspergillosis:single-centre evaluation and meta-analysis. Indian Journal of MedicalMicrobiology. 2022 Apr 1;40(2):204-10.
114.  Biswal M, Gupta P, Kanaujia R, Kaur K, Kaur H, Vyas A, Hallur V, Behera B, Padaki P,Savio J, Nagaraj S. Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India–amulti-centre study. Journal of Hospital Infection. 2022 Apr 1;122:173-9.
115. Kaur R, Dennison SR, Rudramurthy SM, Katare OP, Sharma T, Singh B, Singh KK.Aerosolizable lipid-nanovesicles encapsulating voriconazole effectively permeate pulmonary barriers and target lung cells. Frontiers in Pharmacology.2022 Mar 10;12:734913.
116. Sharma M, Vanam HP, Panda NK, Patro SK, Arora R, Bhadada SK, Rudramurthy SM, Singh MP,Koppula PR. Deciphering the neurosensory olfactory pathway and associated neo-immunometabolic vulnerabilities implicated in COVID-associated mucormycosis(CAM) and COVID-19 in a diabetes backdrop—a novel perspective. Diabetology.2022 Mar 4;3(1):193-235.
117. Gupta P, Kaur H, Mohindra S, Verma S, Rudramurthy S. Recurrent fatal brain abscess by Cladophialophora bantiana in a diabetic patient. Indian Journal of MedicalMicrobiology. 2022 Jan 1;40(1):152-5.
118. Choudhary H, Singh S, Singh R, Agarwal R, Kaur H, Ghosh A, Chakrabarti A, Rudramurthy SM.Rapid and simple reversed-phase high-performance liquid chromatography(RP-HPLC) method for simultaneous quantifications of triazole antifungals in human serum. Mycopathologia. 2021 Mar;186(1):27-39.
119. MuthuV, Kumar M, Paul RA, Zohmangaihi D, Choudhary H, Rudramurthy SM, Panda NK,Pannu AK, Sharma N, Sharma S, Chakrabarti A. Is there an association between zinc and COVID‐19–associated mucormycosis? Results of an experimental and clinical study. Mycoses. 2021 Oct;64(10):1291-7.
120. PatelA, Agarwal R, Rudramurthy SM, Shevkani M, Xess I, Sharma R, Savio J, SethuramanN, Madan S, Shastri P, Thangaraju D. Multicenter epidemiologic study of coronavirus disease–associated mucormycosis, India. Emerging infectiousdiseases. 2021 Sep;27(9):2349.
121.  PrakashH, Skiada A, Paul RA, Chakrabarti A, Rudramurthy SM. Connecting the dots:interplay of pathogenic mechanisms between COVID-19 disease and mucormycosis.Journal of Fungi. 2021 Jul 29;7(8):616.
122.  ShawD, Ghosh AK, Paul S, et al. Matrix-assisted laser desorption/ionisation-time offlight mass spectrometry: Protocol standardisation, comparison and database expansion for faster and reliable identification of dermatophytes. Mycoses.2021;64(8):926-935. doi:10.1111/myc.13285
123. PaulS, Dadwal R, Singh S, Shaw D, Chakrabarti A, Rudramurthy SM, Ghosh AK. Rapid detection of ERG11 polymorphism associated azole resistance in Candida tropicalis. PLoS One. 2021 Jan 13;16(1):e0245160.
124.  Honnavar P, Chakrabarti A, Dhaliwal M, Dogra S, Handa S, Lakshmi PV, Rudramurthy SM.Sociodemographic characteristics and spectrum of Malassezia species in individuals with and without seborrhoeic dermatitis/dandruff: a comparison ofresidents of the urban and rural populations. Medical Mycology. 2021Mar;59(3):259-65.
125.  RudramurthySM, Shankarnarayan SA, Hemashetter BM, Verma S, Chauhan S, Nath R, Savio J,Capoor M, Kaur H, Ghosh AK, Chakrabarti A. Phenotypic and molecular characterisation of Sporothrix globosa of diverse origin from India. BrazilianJournal of Microbiology. 2021 Mar;52(1):91-100.
126.  DasS, Singh S, Tawde Y, Chakrabarti A, Rudramurthy SM, Kaur H, Shankarnarayan SA,Ghosh A. A selective medium for isolation and detection of Candida auris, anemerging pathogen. Journal of Clinical Microbiology. 2021 Jan 21;59(2):10-128.
127. NarayananA, Vadnala RN, Ganguly P, Selvakumar P, Rudramurthy SM, Prasad R, ChakrabartiA, Siddharthan R, Sanyal K. Functional and comparative analysis of centromeres reveals clade-specific genome rearrangements in Candida auris and a chromosome number change in related species. MBio. 2021 Jul 7;12(3):10-128.
128. Verma SB, Panda S, Nenoff P, Singal A, Rudramurthy SM, Uhrlass S, Das A, Bisherwal K,Shaw D, Vasani R. The unprecedented epidemic-like scenario of dermatophytosisin India: III. Antifungal resistance and treatment options. Indian Journal of Dermatology, Venereology and Leprology. 2021 Jun 30;87(4):468-82.
129. ShuklaM, Chandley P, Kaur H, Ghosh AK, Rudramurthy SM, Rohatgi S. Expression andpurification along with evaluation of serological response and diagnosticpotential of recombinant Sap2 protein from C. parapsilosis for use in systemiccandidiasis. Journal of Fungi. 2021 Nov 23;7(12):999.
130. MuthuV, Rudramurthy SM, Chakrabarti A, Agarwal R. Epidemiology and pathophysiologyof COVID-19-associated mucormycosis: India versus the rest of the world.Mycopathologia. 2021 Dec;186(6):739-54.
131. UmamaheshwariS, Neelambike SM, Shankarnarayan SA, Kumarswamy KS, Gopal S, Prakash H,Rudramurthy SM. Clinical profile, antifungal susceptibility, and molecularcharacterization of Candida auris isolated from patients in a South Indiansurgical ICU. Journal of Medical Mycology. 2021 Dec 1;31(4):101176.
132.  KaurR, Dennison SR, Burrow AJ, Rudramurthy SM, Swami R, Gorki V, Katare OP, KaushikA, Singh B, Singh KK. Nebulised surface-active hybrid nanoparticles ofvoriconazole for pulmonary Aspergillosis demonstrate clathrin-mediated cellularuptake, improved antifungal efficacy and lung retention. Journal ofNanobiotechnology. 2021 Jan 11;19(1):19.
133. SekarA, Gupta A, Rawat A, Rudramurthy SM, Kumar R, Bhatia A. Persistent pneumonia inan infant. Indian Pediatrics. 2021 Nov;58(11):1067-73.
134.   JhaK, Shaw D, Karim A, Narang T, Saikia B, Rudramurthy SM, Saikia UN, Dogra S.Immunological response and clinical profile in patients with recurrentdermatophytosis. Mycoses. 2021 Nov;64(11):1429-41.
135. KaurH, Singh S, Rudramurthy SM, Jayashree M, Peters NJ, Ray P, Samujh R, Ghosh A,Chakrabarti A. Fungaemia due to rare yeasts in paediatric intensive care units:A prospective study. Mycoses. 2021 Nov;64(11):1387-95.
136.  RudramurthySM, Hoenigl M, Meis JF, Cornely OA, Muthu V, Gangneux JP, Perfect J,Chakrabarti A, ECMM and ISHAM. ECMM/ISHAM recommendations for clinicalmanagement of COVID‐19 associated mucormycosis in low‐and middle‐incomecountries. Mycoses. 2021 Sep;64(9):1028-37.
137.  HallurV, Prakash H, Sable M, Preetam C, Purushotham P, Senapati R, Shankarnarayan SA,Bag ND, Rudramurthy SM. Cunninghamella arunalokei a new species ofCunninghamella from India causing disease in an immunocompetent individual.Journal of Fungi. 2021 Aug 19;7(8):670.
138. SinghS, Rudramurthy SM, Padhye AA, Hemashetter BM, Iyer R, Hallur V, Sharma A,Agnihotri S, Gupta S, Ghosh A, Kaur H. Clinical spectrum, molecularcharacterization, antifungal susceptibility testing of Exophiala spp. fromIndia and description of a novel Exophiala species, E. arunalokei sp. nov.Frontiers in Cellular and Infection Microbiology. 2021 Jul 2;11:686120.
139. KumarM, Singh A, Kumari S, Kumar P, Wasi M, Mondal AK, Rudramurthy SM, ChakrabartiA, Gaur NA, Gow NA, Prasad R. Sphingolipidomics of drug resistant Candida aurisclinical isolates reveal distinct sphingolipid species signatures. Biochimicaet Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids. 2021 Jan1;1866(1):158815.
140.   SinghS, Pal N, Chander J, Sardana R, Mahajan B, Joseph N, Chakrabarti A, RudramurthySM, Hariprasath P, Paul S, Kaur H. Mucormycosis caused by Syncephalastrum spp.:clinical profile, molecular characterization, antifungal susceptibility andreview of literature. Clinical Infection in Practice. 2021 Jul 1;11:100074.
141.   PamidimukkalaU, Sudhaharan S, Kancharla A, Vemu L, Challa S, Karanam SD, Chavali P, PrakashH, Ghosh AK, Gupta S, Rudramurthy SM. Mucormycosis due to Apophysomyces speciescomplex-25 years’ experience at a tertiary care hospital in southern India.Medical mycology. 2020 Jun 1;58(4):425-33.
142. RavalKM, Ghormade V, Rajamohanan PR, Choudhary H, Rudramurthy SM, Chakrabarti A,Paknikar K. Development of a nano-gold immunodiagnostic assay for rapid on-sitedetection of invasive aspergillosis. Journal of Medical Microbiology. 2019Sep;68(9):1341-52.
143. TunsagoolP, Ploypetch S, Jaresitthikunchai J, Roytrakul S, Choowongkomon K,Rattanasrisomporn J. Efficacy of cyclic lipopeptides obtained from Bacillussubtilis to inhibit the growth of Microsporum canis isolated from cats.Heliyon. 2021 Sep 1;7(9).
144. KaurH, Kanaujia R, Rudramurthy SM. Rhizopus homothallicus: An emerging pathogen inera of COVID-19 associated mucormycosis. Indian Journal of MedicalMicrobiology. 2021 Jul 12;39(4):473.
145.  PrakashH, Karuppiah P, A Al-Dhabi N, Prasad GS, Badapanda C, Chakrabarti A,Rudramurthy SM. Comparative genomics of Sporothrix species and identificationof putative pathogenic-gene determinants. Future Microbiology. 2020 Oct1;15(15):1465-81.
146. PaulS, Singh S, Chakrabarti A, Rudramurthy SM, Ghosh AK. Selection and evaluationof appropriate reference genes for RT-qPCR based expression analysis in Candidatropicalis following azole treatment. Scientific Reports. 2020 Feb6;10(1):1972.
147.  VanamHP, Karumuri SR, Poojari SS, Rudramurthy SM. Mycosis of the Plantar Surface ofFoot Owing to Nondermatophyte Mold Nodulisporium griseobrunneum Mimicking aTinea Pedis. Mycopathologia. 2020 Dec;185(6):1033-40.
148. KumarA, Nair R, Kumar M, Banerjee A, Chakrabarti A, Rudramurthy SM, Bagga R, GaurNA, Mondal AK, Prasad R. Assessment of antifungal resistance and associatedmolecular mechanism in Candida albicans isolates from different cohorts ofpatients in North Indian state of Haryana. Folia Microbiologica. 2020Aug;65(4):747-54.
149.  GhoshA, Kaur H, Gupta A, Singh S, Rudramurthy SM, Gupta S, Chakrabarti A. Emergingdematiaceous and hyaline fungi causing keratitis in a tertiary care centre fromNorth India. Cornea. 2020 Jul 1;39(7):868-76.
150. ShawD, Singh S, Dogra S, Jayaraman J, Bhat R, Panda S, Chakrabarti A, Anjum N,Chowdappa A, Nagamoti M, Varshney U. MIC and upper limit of wild-typedistribution for 13 antifungal agents against a Trichophytonmentagrophytes-Trichophyton interdigitale complex of Indian origin.Antimicrobial agents and chemotherapy. 2020 Mar 24;64(4):10-128.
151. PrakashH, Singh S, Rudramurthy SM, Singh P, Mehta N, Shaw D, Ghosh AK. An aeromycological analysis of Mucormycetes in indoor and outdoor environments ofnorthern India. Medical mycology. 2020 Jan 1;58(1):118-23.
152.DasS, Tawde Y, Singh S, Chakrabarti A, Ray P, Rudramurthy SM, Kaur H, Ghosh A.Identification and broth-microdilution antifungal susceptibility testing ofyeast directly from automated blood cultures. Future Microbiology. 2020 Oct1;15(15):1453-64.
153. ShahiG, Kumar M, Kumari S, Rudramurthy SM, Chakrabarti A, Gaur NA, Singh A, PrasadR. A detailed lipidomic study of human pathogenic fungi Candida auris. FEMSYeast Research. 2020 Sep;20(6):foaa045.
154. PaulS, Singh S, Sharma D, Chakrabarti A, Rudramurthy SM, Ghosh AK. Dynamics of invitro development of azole resistance in Candida tropicalis. Journal of globalantimicrobial resistance. 2020 Sep 1;22:553-61.
155. RudramurthySM, Singh S. Candida infections in immunocompetent hosts: pathogenesis anddiagnosis. Current Fungal Infection Reports. 2020 Sep;14(3):233-45.
156. ShastriPS, Shankarnarayan SA, Oberoi J, Rudramurthy SM, Wattal C, Chakrabarti A.Candida auris candidaemia in an intensive care unit–prospective observationalstudy to evaluate epidemiology, risk factors, and outcome. Journal of CriticalCare. 2020 Jun 1;57:42-8.
157. KaurH, Shankarnarayana SA, Hallur V, Muralidharan J, Biswal M, Ghosh AK, Ray P,Chakrabarti A, Rudramurthy SM. Prolonged outbreak of Candida krusei candidemiain paediatric ward of tertiary care hospital. Mycopathologia. 2020Apr;185(2):257-68.
158. HonnavarP, Dogra S, Handa S, Chakrabarti A, Rudramurthy SM. Molecular identificationand quantification of Malassezia species isolated from pityriasis versicolor.Indian Dermatology Online Journal. 2020 Mar 1;11(2):167-70.
159.  KaurH, Singh S, Rudramurthy SM, Ghosh AK, Jayashree M, Narayana Y, Ray P,Chakrabarti A. Candidaemia in a tertiary care centre of developing country:Monitoring possible change in spectrum of agents and antifungal susceptibility.Indian journal of medical microbiology. 2020 Jan 1;38(1):109-16.
160. ShankarnarayanSA, Shaw D, Sharma A, Chakrabarti A, Dogra S, Kumaran MS, Kaur H, Ghosh A,Rudramurthy SM. Rapid detection of terbinafine resistance in Trichophytonspecies by Amplified refractory mutation system-polymerase chain reaction.Scientific Reports. 2020 Jan 28;10(1):1297.
161.  KanaujiaR, Rudramurthy SM. Masquerading facial lesion: An unusual mycosis. IndianJournal of Medical Research. 2020 Nov 1;152(Suppl 1):S194-5.
162. ChakrabartiA, Sood P, Rudramurthy SM, Chen S, Jillwin J, Iyer R, Sharma A, Harish BN, RoyI, Kindo AJ, Chhina D. Characteristics, outcome and risk factors for mortalityof paediatric patients with ICU‐acquired candidemia in India: A multicentreprospective study. Mycoses. 2020 Nov;63(11):1149-63.
163. PatelA, Kaur H, Xess I, Michael JS, Savio J, Rudramurthy S, Singh R, Shastri P,Umabala P, Sardana R, Kindo A. A multicentre observational study on theepidemiology, risk factors, management and outcomes of mucormycosis in India.Clinical microbiology and infection. 2020 Jul 1;26(7):944-e9.
164. R Rudramurthy SM,Colley T, Abdolrasouli A, Ashman J, Dhaliwal M, Kaur H, Armstrong-James D,Strong P, Rapeport G, Schelenz S, Ito K. In vitro antifungal activity of anovel topical triazole PC945 against emerging yeast Candida auris. Journal ofAntimicrobial Chemotherapy. 2019 Oct 1;74(10):2943-9.
165. SinghR, Kaur M, Chakrabarti A, Shankarnarayan SA, Rudramurthy SM. Biofilm formationby Candida auris isolated from colonising sites and candidemia cases. Mycoses.2019 Aug;62(8):706-9.
166. ChakrabartiA, Kaur H, Savio J, Rudramurthy SM, Patel A, Shastri P, Pamidimukkala U,Karthik R, Bhattacharya S, Kindo AJ, Bhattacharya P. Epidemiology and clinicaloutcomes of invasive mould infections in Indian intensive care units (FISFstudy). Journal of Critical Care. 2019 Jun 1;51:64-70.
167.  PrakashH, Ghosh AK, Rudramurthy SM, Singh P, Xess I, Savio J, Pamidimukkala U, JillwinJ, Varma S, Das A, Panda NK. A prospective multicenter study on mucormycosis inIndia: Epidemiology, diagnosis, and treatment. Medical mycology. 2019 Jun1;57(4):395-402.
168.    PaulS, Singh S, Chakrabarti A, Rudramurthy SM, Ghosh AK. Stable isotope labelling:an approach for MALDI-TOF MS-based rapid detection of fluconazole resistance inCandida tropicalis. Journal of Antimicrobial Chemotherapy. 2019 May1;74(5):1269-76.
169. GhoshAK, Rudramurthy SM, Gupta A, Choudhary H, Singh S, Thakur A, Jatana M.Evaluation of liposomal and conventional amphotericin B in experimental fungalkeratitis rabbit model. Translational vision science & technology. 2019 May1;8(3):35-.
170.   DograS, Shaw D, Rudramurthy SM. Antifungal drug susceptibility testing ofdermatophytes: Laboratory findings to clinical implications. Indian dermatologyonline journal. 2019 May 1;10(3):225-33.
171.  PaulS, Singh P, Sharma S, Prasad GS, Rudramurthy SM, Chakrabarti A, Ghosh AK.MALDI‐TOF MS‐based identification of melanized fungi is faster and reliableafter the expansion of in‐house database. PROTEOMICS–Clinical Applications.2019 May;13(3):1800070.
172.  ShahJ, Dutta U, Rudramurthy S, Chakrabarti A, Sinha SK, Sharma V, Mandavdhare H,Sharma P, Kalsi D, Popli P, Radhika S. Colonic mucosa‐associated candidaassessed by biopsy culture is associated with disease severity in ulcerativecolitis: A prospective study. Journal of Digestive Diseases. 2019Dec;20(12):642-8.
173.  DubeyN, Capoor MR, Hasan AS, Gupta A, Ramesh V, Sharma S, Singh A, Rudramurthy SM,Chakrabarti A. Epidemiological profile and spectrum of neglected tropicaldisease eumycetoma from Delhi, North India. Epidemiology & Infection. 2019Jan;147:e294.
174.  BorgohainP, Barua P, Dutta PJ, Shaw D, Rudramurthy SM. Onychomycosis associated withsuperficial skin infection due to Aspergillus sydowii in an immunocompromisedpatient. Mycopathologia. 2019 Oct;184(5):683-9.
175.   WasiM, Khandelwal NK, Moorhouse AJ, Nair R, Vishwakarma P, Bravo Ruiz G, Ross ZK,Lorenz A, Rudramurthy SM, Chakrabarti A, Lynn AM. ABC transporter genes showupregulated expression in drug-resistant clinical isolates of Candida auris: agenome-wide characterization of ATP-binding cassette (ABC) transporter genes.Frontiers in microbiology. 2019 Jul 16;10:1445.
176.   PaulRA, Rudramurthy SM, Dhaliwal M, Singh P, Ghosh AK, Kaur H, Varma S, Agarwal R,Chakrabarti A. Magnitude of voriconazole resistance in clinical andenvironmental isolates of Aspergillus flavus and investigation into the role ofmultidrug efflux pumps. Antimicrobial agents and chemotherapy. 2018Nov;62(11):10-128.
177.  SinghS, Kaur H, Choudhary H, Sethi S, Malhotra P, Gupta KL, Rudramurthy SM,Chakrabarti A. Evaluation of biomarkers: Galactomannan and 1, 3-beta-D-glucanassay for the diagnosis of invasive fungal infections in immunocompromisedpatients from a tertiary care centre. Indian journal of medical microbiology.2018 Oct 1;36(4):557-63.
178.  ShankarnarayanSA, Rudramurthy SM, Chakrabarti A, Shaw D, Paul S, Sethuraman N, Kaur H, GhoshAK. Molecular typing and antifungal susceptibility of Candida viswanathii,India. Emerging Infectious Diseases. 2018 Oct;24(10):1956.
179. PathaniaS, Rudramurthy SM, Narang T, Saikia UN, Dogra S. A prospective study of theepidemiological and clinical patterns of recurrent dermatophytosis at atertiary care hospital in India. Indian Journal of Dermatology, Venereology andLeprology. 2018 Nov 1;84:678.
180. HonnavarP, Ghosh AK, Paul S, Shankarnarayan SA, Singh P, Dogra S, Chakrabarti A,Rudramurthy SM. Identification of Malassezia species by MALDI-TOF MS afterexpansion of database. Diagnostic microbiology and infectious disease. 2018 Oct1;92(2):118-23.
181. HonnavarP, Chakrabarti A, Prasad GS, Joseph J, Dogra S, Handa S, Rudramurthy SM. TheLipase Activities of Malassezia Species Isolated from SeborrhoeicDermatitis/Dandruff Patients. Journal of Clinical & Diagnostic Research.2018 May 1;12(5).
182.  RudramurthySM, Shankarnarayan SA, Dogra S, Shaw D, Mushtaq K, Paul RA, Narang T,Chakrabarti A. Mutation in the squalene epoxidase gene of Trichophytoninterdigitale and Trichophyton rubrum associated with allylamine resistance.Antimicrobial agents and chemotherapy. 2018 May;62(5):10-128.
183.  DarSA, Rai G, Ansari MA, Akhter N, Gupta N, Sharma S, Haque S, Ramachandran VG,Wahid M, Rudramurthy SM, Chakrabarti A. FcɛR1α gene polymorphism showsassociation with high IgE and anti‐FcɛR1α in Chronic Rhinosinusitis with NasalPolyposis. Journal of Cellular Biochemistry. 2018 May;119(5):4142-9.
184.  SainiAG, Patil S, Agrawal T, Basha A, Garg R, Rudramurthy SM, Vaidya P, Saxena A,Singhi P. Systemic cryptococcosis in an immune-competent child. Journal ofInfection and Public Health. 2018 May 1;11(3):436-8.
185. VanamHP, Rao PN, Mohanram K, Yegneswaran PP, Rudramurthy SP. Distal lateralsubungual onychomycosis owing to Tritirachium oryzae: a bystander or invader?.Mycopathologia. 2018 Apr;183(2):459-63.
186.  PaulS, Singh P, AS S, Rudramurthy SM, Chakrabarti A, Ghosh AK. Rapid detection offluconazole resistance in Candida tropicalis by MALDI-TOF MS. Medical mycology.2018 Feb 1;56(2):234-41.
187.   RotjanapanP, Chen YC, Chakrabarti A, Li RY, Rudramurthy SM, Yu J, Kung HC, WatcharanananS, Tan AL, Saffari SE, Tan BH. Epidemiology and clinical characteristics ofinvasive mould infections: a multicenter, retrospective analysis in five Asiancountries. Medical mycology. 2018 Feb 1;56(2):186-96.
188.   RaiG, Ansari MA, Dar SA, Datt S, Gupta N, Sharma S, Haque S, Ramachandran VG,Mazumdar A, Rudramurthy S, Chakrabarti A. Clinical and Cytogenetic Profiles ofRhabdomyosarcoma with Bone Marrow Involvement in Korean Children: A 15-YearSingle-Institution Experience. Annals of Laboratory Medicine. 2018Mar;38(2):125-31.
189.  RudramurthySM, Sharma M, Sharma M, Rawat P, Ghosh A, Venkatesan L, Aggarwal R, Singh M,Chakrabarti A. Reliable differentiation of Pneumocystis pneumonia fromPneumocystis colonisation by quantification of Major Surface Glycoprotein geneusing real‐time polymerase chain reaction. Mycoses. 2018 Feb;61(2):96-103.
190. PrakashH, Rudramurthy SM, Gandham PS, Ghosh AK, Kumar MM, Badapanda C, Chakrabarti A.Apophysomyces variabilis: draft genome sequence and comparison of predictivevirulence determinants with other medically important Mucorales. BMC genomics.2017 Sep 18;18(1):736.
191. ZamanK, Rudramurthy SM, Das A, Panda N, Honnavar P, Kaur H, Chakrabarti A. Moleculardiagnosis of rhino-orbito-cerebral mucormycosis from fresh tissue samples.Journal of medical microbiology. 2017 Aug;66(8):1124-9.
192  PaulS, Singh P, Rudramurthy SM, Chakrabarti A, Ghosh AK. Matrix-assisted laserdesorption/ionization–time of flight mass spectrometry: protocolstandardization and database expansion for rapid identification of clinicallyimportant molds. Future Microbiology. 2017 Dec 1;12(16):1457-66.
193.  BiswalM, Rudramurthy SM, Jain N, Shamanth AS, Sharma D, Jain K, Yaddanapudi LN,Chakrabarti A. Controlling a possible outbreak of Candida auris infection:lessons learnt from multiple interventions. Journal of Hospital Infection. 2017Dec 1;97(4):363-70.
194. GoelG, Chandy M, Bhattacharyya A, Banerjee S, Chatterjee S, Mullick S, Sinha S,Sengupta K, Dhar K, Bhattacharya S, Rudramurthy S. Mortality associated withcandidemia in non-neutropenic cancer patients is not less compared to aneutropenic cohort of cancer patients. European Journal of ClinicalMicrobiology & Infectious Diseases. 2017 Dec;36(12):2533-5.
195. RudramurthySM, Chakrabarti A, Paul RA, Sood P, Kaur H, Capoor MR, Kindo AJ, Marak RS,Arora A, Sardana R, Das S. Candida auris candidaemia in Indian ICUs: analysisof risk factors. Journal of Antimicrobial Chemotherapy. 2017 Jun1;72(6):1794-801.
196. RawatA, Vignesh P, Sharma A, Shandilya JK, Sharma M, Suri D, Gupta A, Gautam V, RayP, Rudramurthy SM, Chakrabarti A. Infection profile in chronic granulomatousdisease: a 23-year experience from a tertiary care center in North India.Journal of clinical immunology. 2017 Apr;37(3):319-28.
197. HonnavarP, Chakrabarti A, Prasad GS, Singh P, Dogra S, Rudramurthy SM. β-Endorphinenhances the phospholipase activity of the dandruff causing fungi Malasseziaglobosa and Malassezia restricta. Medical mycology. 2017 Feb 1;55(2):150-4.
198.    RudramurthySM, Seyedmousavi S, Dhaliwal M, Chakrabarti A, Meis JF, Mouton JW.Pharmacodynamics of voriconazole against wild-type and azole-resistantAspergillus flavus isolates in a nonneutropenic murine model of disseminatedaspergillosis. Antimicrobial Agents and Chemotherapy. 2017 Jan;61(1):10-128.
199. NagarathnammaT, Chunchanur SK, Rudramurthy SM, Vineetha KR, Ramamurthy K, Joseph J, AmbicaR. Outbreak of Pichia kudriavzevii fungaemia in a neonatal intensive care unit.Journal of Medical Microbiology. 2017 Dec;66(12):1759-64.
200. GhoshAK, Gupta A, Rudramurthy SM, Paul S, Hallur VK, Chakrabarti A. Fungal keratitisin North India: spectrum of agents, risk factors and treatment. Mycopathologia.2016 Dec;181(11):843-50.
201. RudramurthySM, Singh G, Hallur V, Verma S, Chakrabarti A. High fungal spore burden withpredominance of Aspergillus in hospital air of a tertiary care hospital inChandigarh. Indian Journal of Medical Microbiology. 2016 Oct 1;34(4):529-32.
202.  SinghP, Paul S, Shivaprakash MR, Chakrabarti A, Ghosh AK. Stress response in medicallyimportant Mucorales. Mycoses. 2016 Oct;59(10):628-35.
203.  G Gaspar BL, AgarwalR, Gupta K, Shivaprakash MR. Aspergillus pseudomembranous tracheobronchitis inan immunocompetent individual: a diagnostic conundrum with therapeuticchallenge. Lung India. 2016 Sep 1;33(5):550-2.
204.  PrakashH, Ghosh AK, Rudramurthy SM, Paul RA, Gupta S, Negi V, Chakrabarti A. Theenvironmental source of emerging Apophysomyces variabilis infection in India.Sabouraudia. 2016 Apr 26;54(6):567-75.
205. RastogiV, Honnavar P, Rudramurthy SM, Pamidi U, Ghosh A, Chakrabarti A. Molecularcharacterisation and antifungal susceptibility of clinical Trichosporonisolates in India. Mycoses. 2016 Aug;59(8):528-34.
206. HonnavarP, Prasad GS, Ghosh A, Dogra S, Handa S, Rudramurthy SM. Malassezia arunalokeisp. nov., a novel yeast species isolated from seborrheic dermatitis patientsand healthy individuals from India. Journal of clinical microbiology. 2016Jul;54(7):1826-34.
207. DhatwaliaSK, Yadav R, Behera D, Rudramurthy SM, Kaur H, Sethi S. Distribution andassociation of Mycobacterium tuberculosis CAS lineage with multidrug resistancein North India. The International Journal of Tuberculosis and Lung Disease.2016 Jun 1;20(6):806-11.
208.  SubramanyaSupram H, Gokhale S, Chakrabarti A, Rudramurthy SM, Gupta S, Honnavar P.Emergence of Magnusiomyces capitatus infections in Western Nepal. Sabouraudia.2015 Oct 18;54(2):103-10.
209. ChakrabartiA, Kaur H, Rudramurthy SM, Appannanavar SB, Patel A, Mukherjee KK, Ghosh A, RayU. Brain abscess due to Cladophialophora bantiana: a review of 124 cases.Sabouraudia. 2015 Oct 18;54(2):111-9.
210. RudramurthySM, Honnavar P, Kaur H, Samanta P, Ray P, Ghosh A, Chakrabarti A. Molecularidentification of clinical Nocardia isolates from India. Journal of medicalmicrobiology. 2015 Oct;64(10):1216-25.
211. PaulRA, Rudramurthy SM, Meis JF, Mouton JW, Chakrabarti A. A novel Y319Hsubstitution in CYP51C associated with azole resistance in Aspergillus flavus.Antimicrobial Agents and Chemotherapy. 2015 Oct;59(10):6615-9.
212.  ChouguleA, Muthu V, Bal A, Rudramurthy SM, Dhooria S, Das A, Singh H. Pulmonarygangrene due to Rhizopus spp., Staphylococcus aureus, Klebsiella pneumoniae andprobable Sarcina organisms. Mycopathologia. 2015 Aug;180(1):131-6.
213.    GhoshAK, Paul S, Sood P, Rudramurthy SM, Rajbanshi A, Jillwin TJ, Chakrabarti A.Matrix-assisted laser desorption ionization time-of-flight mass spectrometryfor the rapid identification of yeasts causing bloodstream infections. ClinicalMicrobiology and Infection. 2015 Apr 1;21(4):372-8.
214.  ChakrabartiA, Sood P, Rudramurthy SM, Chen S, Kaur H, Capoor M, Chhina D, Rao R, EshwaraVK, Xess I, Kindo AJ. Incidence, characteristics and outcome of ICU-acquiredcandidemia in India. Intensive care medicine. 2015 Feb;41(2):285-95.
215.  KaleP, Rudramurthy SM, Panda NK, Das A, Chakrabarti A. The inflammatory response ofeosinophil-related fungal rhinosinusitis varies with inciting fungi. Medicalmycology. 2015 May 1;53(4):387-95.
216. ChakrabartiA, Rudramurthy SM, Panda N, Das A, Singh A. Epidemiology of chronic fungalrhinosinusitis in rural India. Mycoses. 2015 May;58(5):294-302.
217. HonnavarP, Chakrabarti A, Dogra S, Handa S, Rudramurthy SM. Phenotypic and molecularcharacterization of Malassezia japonica isolated from psoriasis vulgarispatients. Journal of Medical Microbiology. 2015 Mar;64(3):232-6.
218 RudramurthySM, Honnavar P, Chakrabarti A, Dogra S, Singh P, Handa S. Association ofMalassezia species with psoriatic lesions. Mycoses. 2014 Aug;57(8):483-8.
219.  RudramurthySM, Honnavar P, Dogra S, Yegneswaran PP, Handa S, Chakrabarti A. Association ofMalassezia species with dandruff. Indian Journal of Medical Research. 2014 Mar1;139(3):431-7.
220. ChakrabartiA, Rudramurthy SM, Kale P, Hariprasath P, Dhaliwal M, Singhi S, Rao KL.Epidemiological study of a large cluster of fungaemia cases due to Kodamaeaohmeri in an Indian tertiary care centre. Clinical Microbiology and Infection.2014 Feb 1;20(2):O83-9.
221.   GuptaP, Chakrabarti A, Singhi S, Kumar P, Honnavar P, Rudramurthy SM. Skincolonization by Malassezia spp. in hospitalized neonates and infants in atertiary care centre in North India. Mycopathologia. 2014 Oct;178(3):267-72. 
222.  JhaAK, Bansal D, Chakrabarti A, Shivaprakash MR, Trehan A, Marwaha RK. Serumgalactomannan assay for the diagnosis of invasive aspergillosis in childrenwith haematological malignancies. Mycoses. 2013 Jul;56(4):442-8.
223.     HallurV, Singh G, Rudramurthy SM, Kapoor R, Chakrabarti A. Demodex mite infestationof unknown significance in a patient with rhinocerebral mucormycosis due toApophysomyces elegans species complex. Journal of medical microbiology. 2013Jun;62(6):926-8.
224.   RudramurthySM, Jatana M, Singh R, Chakrabarti A. In vitro antifungal activity of Indianliposomal amphotericin B against clinical isolates of emerging species of yeastand moulds, and its comparison with amphotericin B deoxycholate, voriconazole,itraconazole and fluconazole. Mycoses. 2013 Jan;56(1):39-46.
225.  PatilA, Chandramohan K, Shivaprakash M, Nadgir S, Lakshminarayana S. Rhizomucorvariabilis: a rare causative agent of primary cutaneous zygomycosis. IndianJournal of Medical Microbiology. 2013 Jul 1;31(3):302.
226.  RudramurthySM, Chakrabarti A, Geertsen E, Mouton JW, Meis JF. In vitro activity ofisavuconazole against 208 Aspergillus flavus isolates in comparison with 7other antifungal agents: assessment according to the methodology of theEuropean Committee on Antimicrobial Susceptibility Testing. Diagnosticmicrobiology and infectious disease. 2011 Dec 1;71(4):370-7.
227.  ShivaprakashMR, Geertsen E, Chakrabarti A, Mouton JW, Meis JF. In vitro susceptibility of188 clinical and environmental isolates of Aspergillus flavus for the newtriazole isavuconazole and seven other antifungal drugs. Mycoses. 2011Sep;54(5):e583-9.
228. SinghR, Shivaprakash MR, Chakrabarti A. Biofilm formation by zygomycetes:quantification, structure and matrix composition. Microbiology. 2011Sep;157(9):2611-8.
229. RudramurthySM, de Valk HA, Chakrabarti A, Meis JF, Klaassen CH. High resolution genotypingof clinical Aspergillus flavus isolates from India using microsatellites. PLoSOne. 2011 Jan 17;6(1):e16086.
230. ChakrabartiA, Shivaprakash MR, Curfs-Breuker I, Baghela A, Klaassen CH, Meis JF.Apophysomyces elegans: epidemiology, amplified fragment length polymorphismtyping, and in vitro antifungal susceptibility pattern. Journal of clinicalmicrobiology. 2010 Dec;48(12):4580-5.
231.  BaghelaA, Thungapathra M, Shivaprakash MR, Chakrabarti A. Multilocus microsatellitetyping for Rhizopus oryzae. Journal of medical microbiology. 2010Dec;59(12):1449-55.
232.   ChakrabartiA, Chatterjee SS, Das A, Panda N, Shivaprakash MR, Kaur A, Varma SC, Singhi S,Bhansali A, Sakhuja V. Invasive zygomycosis in India: experience in a tertiarycare hospital. Postgraduate medical journal. 2009 Nov;85(1009):573-81.
233.  ChakrabartiA, Chatterjee SS, Rao KL, Zameer MM, Shivaprakash MR, Singhi S, Singh R, VarmaSC. Recent experience with fungaemia: change in species distribution and azoleresistance. Scandinavian journal of infectious diseases. 2009 Jan1;41(4):275-84.
234. ChakrabartiA, SHIVAPRAKASH MR, Singh R, Tarai B, George VK, Fomda BA, Gupta A. Fungalendophthalmitis: fourteen years’ experience from a center in India. Retina.2008 Nov 1;28(10):1400-7.
235.   Shivaprakash MR, Rao P, Mandal J, Biswal M, Gupta S, Ray P, Chakrabarti A. Nocardiosis in atertiary care hospital in North India and review of patients reported fromIndia. Mycopathologia. 2007 May;163(5):267-74.
236. ChakrabartiA, Rao P, Tarai B, Shivaprakash MR, Wig J. Candida in acute pancreatitis.Surgery today. 2007 Mar;37(3):207-11.
237.  ChakrabartiA, Das A, Mandal J, Shivaprakash MR, George VK, Tarai B, Rao P, Panda N, VermaSC, Sakhuja V. The rising trend of invasive zygomycosis in patients withuncontrolled diabetes mellitus. Sabouraudia. 2006 Jun 1;44(4):335-42.
238. TaraiB, Gupta A, Ray P, Shivaprakash MR, Chakrabarti A. Polymerase chain reactionfor early diagnosis of post-operative fungal endophthalmitis. Indian Journal ofMedical Research. 2006 May 1;123(5):671.
239. ShivaprakashMR, Rajagopal V, Nagarathna S. Latex agglutination test in the diagnosis ofpyogenic meningitis. The Journal of Communicable Diseases. 2004 Jun1;36(2):127-31.
240. ParijaSC, Shivaprakash MR, Jayakeerthi SR. Evaluation of lacto-phenol cotton blue(LPCB) for detection of Cryptosporidium, Cyclospora and Isospora in the wetmount preparation of stool. Acta tropica. 2003 Mar 1;85(3):349-54.
241. ParijaSC, Bhattacharya S, Padhan P, Shivaprakash MR. Evaluation of Formalin—AcetoneSedimentation in the Concentration of Stool for Intestinal Parasites. Tropicaldoctor. 2003 Jul;33(3):163-4.
242.  ShivaprakashMR, Parija SC, Sujatha S. Seroprevalence of toxoplasmosis in HIV infectedpatients in Pondicherry.
243.  Parija SC, Sheeladevi C,Shivaprakash MR, Biswal N. Evaluation of lacto-phenol cotton blue stain fordetection of eggs of Enterobius vermicularis in perianal surface samples.Tropical doctor. 2001 Oct;31(4):214-5.
244.  ShivaprakashMR, Appannanavar SB, Dhaliwal M, Gupta A, Gupta S, Gupta A, Chakrabarti A.Colletotrichum truncatum: an unusual pathogen causing mycotic keratitis andendophthalmitis. Journal of clinical microbiology. 2011 Aug;49(8):2894-8.
245.  Kaur H, Gupta P,Pilania R, Suri D, Singh S, Ghosh A, Rudramurthy SM. Trend of pediatriccryptococcosis in a tertiary care centre and review of literature. IndianJournal of Medical Microbiology. 2023 May 1;43:18-29.
246. Hoenigl M,Seidel D, Carvalho A, Rudramurthy SM, Arastehfar A, Gangneux JP, Nasir N,Bonifaz A, Araiza J, Klimko N, Serris A. The emergence of COVID-19 associatedmucormycosis: a review of cases from 18 countries. The Lancet Microbe. 2022 Jul1;3(7):e543-52.
247. Chakrabarti A,Chatterjee SS, Das A, Shivaprakash MR. Invasive aspergillosis in developingcountries. Medical mycology. 2011 Apr 1;49(Supplement_1):S35-47.
248.  SinghS, Kanaujia R, Kumar MB, Naga Santhosh Irrinki RN, Satish SN, Choudhary H, KaurH, Rudramurthy SM. Saksenaea vasiformis infection: Extensive abdominal wallnecrotizing fasciitis with systematic review and analysis of 65 cases. Mycoses.2023 Aug;66(8):697-704.
249. GargD, Soundappan K, Agarwal R, Mukherjee S, Kumar M, Dhooria S, Sehgal IS, PrasadKT, Ramachandran R, Patil S, Aggarwal AN. Risk factors for pulmonarymucormycosis in subjects with diabetes mellitus—A case‐control study. Mycoses.2023 Sep;66(9):787-94.
250.    RoyU, Jessani LG, Rudramurthy SM, Gopalakrishnan R, Dutta S, Chakravarty C,Jillwin J, Chakrabarti A. Seven cases of Saccharomyces fungaemia related to useof probiotics. Mycoses. 2017 Jun;60(6):375-80.
251. Verma RK, Patro SK, Shivaprakash MR, Chaterjee D, Panda NK. Invasive fungal infections of face–A diagnostic challenge: Case series and review. EgyptianJournal of Ear, Nose, Throat and Allied Sciences. 2015 Nov 1;16(3):231-5.
 
 
Review articles
1.     Singh B, KunduR, Sharma C, Khurana S, Bhujade H, Singla N, Rudramurthy SM. Opportunisticmicrosporidiosis unveiled by fine‐needle aspiration cytology of cervical lymphnode with literature review. Diagnostic Cytopathology. 2024 Mar;52(3):E63-8.
2.     Gudisa R,Harchand R, Rudramurthy SM. Nucleic-acid-based molecular fungal diagnostics: away to a better future. Diagnostics. 2024 Feb 29;14(5):520.
3.     Muthu V, AgarwalR, Dhooria S, Sehgal IS, Prasad KT, Rudramurthy SM, Aggarwal A, Chakrabarti A.Mucormycosis in human immunodeficiency virus-infected individuals: a systematicreview of Case Reports. Mycopathologia. 2023 Oct;188(5):755-63.
4.     Muthu V, DhooriaS, Sehgal IS, Prasad KT, Rudramurthy SM, Aggarwal AN, Chakrabarti A, Agarwal R.Nebulized amphotericin B for preventing exacerbations in allergicbronchopulmonary aspergillosis: A systematic review and meta-analysis.Pulmonary Pharmacology & Therapeutics. 2023 Aug 1;81:102226.
5.     Kanaujia R,Singh S, Rudramurthy SM. Aspergillosis: an update on clinical spectrum,diagnostic schemes, and management. Current Fungal Infection Reports. 2023Jun;17(2):144-55.
6.     Agarwal R, MuthuV, Sehgal IS, Dhooria S, Prasad KT, Soundappan K, Rudramurthy SM, Aggarwal AN,Chakrabarti A. Prevalence of aspergillus sensitization and allergicbronchopulmonary aspergillosis in bronchial asthma: A systematic review ofIndian studies. Lung India. 2023 Nov 1;40(6):527-36.
7.     MuthuV, Agarwal R, Patel A, Kathirvel S, Abraham OC, Aggarwal AN, Bal A, Bhalla AS,Chhajed PN, Chaudhry D, Garg M. Definition, diagnosis, and management ofCOVID-19-associated pulmonary mucormycosis: Delphi consensus statement from theFungal Infection Study Forum and Academy of Pulmonary Sciences, India. TheLancet Infectious Diseases. 2022 Sep 1;22(9):e240-53.
8.     Verma SB, PandaS, Nenoff P, Singal A, Rudramurthy SM, Uhrlass S, Das A, Bisherwal K, Shaw D,Vasani R. The unprecedented epidemic-like scenario of dermatophytosis in India:II. Diagnostic methods and taxonomical aspects. Indian Journal of Dermatology,Venereology and Leprology. 2021 Apr 30;87(3):326-32.
9.     Singh S, VermaN, Kanaujia R, Chakrabarti A, Rudramurthy SM. Mortality in critically illpatients with coronavirus disease 2019‐associated pulmonary aspergillosis: asystematic review and meta‐analysis. Mycoses. 2021 Sep;64(9):1015-27.
10.  Rudramurthy SM, Singh S. Candida infections inimmunocompetent hosts: pathogenesis and diagnosis. Current Fungal InfectionReports. 2020 Sep;14(3):233-45
11.  Rudramurthy SM, Paul RA, Chakrabarti A, Mouton JW,Meis JF. Invasive aspergillosis by Aspergillus flavus: epidemiology, diagnosis,antifungal resistance, and management. Journal of Fungi. 2019 Jul 1;5(3):55.
12.  Rudramurthy SM, Chakrabarti A. Sporotrichosis: Updateon diagnostic techniques. Current Fungal Infection Reports. 2017Sep;11(3):134-40.
13.  Chakrabarti A, Denning DW, Ferguson BJ, Ponikau J,Buzina W, Kita H, Marple B, Panda N, Vlaminck S, Kauffmann‐Lacroix C, Das A.Fungal rhinosinusitis: a categorization and definitional schema addressingcurrent controversies. The Laryngoscope. 2009 Sep;119(9):1809-18.
14.  Das S, Shivaprakash MR, Chakrabarti A. New antifungalagents in pediatric practice. Indian Pediatrics. 2009 Mar 1;46(3).
15.  Harchand R, Spruijtenburg B, Meijer EF, de Groot T,Rudramurthy SM, Meis JF. Candida vulturna, the Next Fungal Menace? A NarrativeReview. Mycoses. 2025 May;68(5):e70070.
16.  Agarwal R, Muthu V, Sehgal IS, Dhooria S, Prasad KT,Soundappan K, Rudramurthy SM, Aggarwal AN, Chakrabarti A. Prevalence ofaspergillus sensitization and allergic bronchopulmonary aspergillosis in adultswith bronchial asthma: a systematic review of global data. The Journal ofAllergy and Clinical Immunology: In Practice. 2023 Jun 1;11(6):1734-51.
17.  Agarwal R, Muthu V, Sehgal IS, Dhooria S, Prasad KT,Soundappan K, Rudramurthy SM, Aggarwal AN, Chakrabarti A. Aspergillussensitization and allergic bronchopulmonary aspergillosis in asthmaticchildren: a systematic review and meta-analysis. Diagnostics. 2023 Mar1;13(5):922.
18.  Kaur H, Ghosh A, Rudramurthy SM, Chakrabarti A.Gastrointestinal mucormycosis in apparently immunocompetent hosts—a review.Mycoses. 2018 Dec;61(12):898-908.
   
 
Case reports
 
1)       KecheA, Patil G, Ganguly S, Gupta R, Rudramurthy SM. Subcutaneous Phaeohyphomycosisdue to a rare fungus Parathyridaria percutanea: First Reported Case fromCentral India. Indian Journal of Medical Microbiology. 2025 Aug 11:100954.
2)       KaurH, Jamir I, Sharma D, Ahmad H, Saroya A, Gupta A, Ghosh A, Rudramurthy SM.Refractory mycotic keratitis by Cephalotheca foveolata: first report fromIndia. Indian journal of medical microbiology. 2025 Jul 18:100938.
3)       BawankarNS, Meshram PP, Bhise SM, Rudramurthy SM, Gupta S. Nodular PulmonaryHistoplasmosis in an Immunocompetent Tile-cutting Worker with Poultry FarmingHistory: A Diagnostic Challenge in a Non-Endemic Region of Central India. TheMicrobe. 2025 Jul 1:100443.case
4)       KaurH, Raj S, Gothwal K, Kenwar D, Muthu V, Ahmad H, Gupta P, Agnihotri S, SharmaA, Rudramurthy SM. Fatal pulmonary mycoses by Emergomyces pasteurianus in arenal transplant recipient from India. Journal of Medical Mycology. 2025 Jun20:101561.
5)       KaurH, Kumar K, Ahmad H, Sharma A, Gupta N, Gupta C, Narang T, Sethi J, AgnihotriS, Srinivasan R, Rudramurthy SM. Concurrent chromoblastomycosis andsubcutaneous phaeohyphomycosis by different pathogens in a renal transplantrecipient. Diagnostic Microbiology and Infectious Disease. 2025 Jun 6:116945.
6)       HallurV, Khan S, Mohapatra D, Paty BP, Mohanty J, Paul D, Gahlot P, Das M,Shivaprakash MR. Expanding geographical niche of emerging pathogen Fonsecaeanubica: First report of its isolation from India from a case ofchromoblastomycosis. Indian journal of medical microbiology. 2025 May 1;55.
7)       RaghavanA, Lorenzo-Morales J, Chabra MK, Rudramurthy S, Venkatapathy N, Narendran S,Rammohan R. A rare case of keratitis due to co-infection with Plectosphaerellacucumerina and Acanthamoeba T5 genotype. American Journal of Ophthalmology CaseReports. 2024 Dec 1;36:102176.
8)       CapoorMR, Sharma S, Goenka S, Das S, Rudramurthy SM, Khunger N. Tinea capitis causedby Microsporum canis: A case study of three family members in India, anon-endemic region. Indian Journal of Medical Microbiology. 2024 Jul1;50:100621
9)       HallurV, Dey R, Sable M, Rudramurthy SM, Dey A. First case report of recurrentcervical lymphadenopathy due to Chordomyces antarcticum. Indian Journal ofMedical Microbiology. 2023 May 1;43:8-10.
10)   GuptaP, Arora A, Gupta M, Singh R, Rudramurthy SM, Kaur H. First case ofendophthalmitis by Corynespora cassiicola. Journal of Medical Mycology. 2022Nov 1;32(4):101298.
11)   GuptaP, Thakur A, Rudramurthy SM, Gupta A, Ghosh A, Kaur H. Initial case report ofCladorrhinum samala mycotic keratitis. Cornea. 2022 Oct 1;41(10):1302-4.
12)   GuptaP, Pilania RK, Kaur H, Rudramurthy SM, Soni R, Batra N, Verma R, Singh S,Chatterjee D. Pediatric case of conidiobolomycosis: A rare entity. PediatricDermatology. 2022 Jan;39(1):149-50.
13)   HallurV, Rath S, Sable M, Kar P, Rudramurthy SM, Mishra T, Deshmukh V. A rare case ofphaeohyphomycosis due to Phaeoacremonium krajdenii from Odisha. Indian Journalof Medical Microbiology. 2022 Jan 1;40(1):172-4.
14)   PurohitG, Sable M, Rudramurthy SM, Sarkar S, Parida P, Deshmukh V, Hallur V. A rarecase of condiobolomycosis due to Conidiobolus coronatus presenting withdysphagia. Indian Journal of Medical Microbiology. 2021 Oct 1;39(4):558-60.
15)   IyerRN, Rao JR, Rudramurthy SM, Kapoor D. Two cases of Nocardia bacteraemia insolid organ transplant recipients. Indian journal of medical microbiology. 2020Jan 1;38(1):123-6.
16)   SubramanyaSH, Jillwin J, Rudramurthy SM, Rijal KC, Nayak N, Chakrabarti A, Ghosh A.Primary invasive laryngeal mycosis in an immunocompetent patient: a case reportand clinico-epidemiological update. BMC Infectious Diseases. 2018 Jul11;18(1):323.
17)   ParmarNV, Asir GJ, Rudramurthy SM. Atypical presentation of Majocchi's granuloma inan immunocompetent host. The American Journal of Tropical Medicine and Hygiene.2017 Jan 11;96(1):1.
18)   CapoorMR, Agarwal P, Goel M, Jain S, Shivaprakash MR, Honnavar P, Gupta S,Chakrabarti A. Invasive pulmonary mycosis due to Chaetomium globosum withfalse‐positive galactomannan test: a case report and literature review.Mycoses. 2016 Mar;59(3):186-93.
19)   PrasadKT, Sehgal IS, Shivaprakash MR, Dhooria S. Uncommon mycosis in a patient withdiabetes. Case Reports. 2016 Feb 25;2016:bcr2016214453.
20)   MalikR, Capoor MR, Vanidassane I, Gogna A, Singh A, Sen B, Rudramurthy SM, HonnavarP, Gupta S, Chakrabarti A. Disseminated Emmonsia pasteuriana infection inIndia: a case report and a review. Mycoses. 2016 Feb;59(2):127-32.
21)   RastogiP, Sharma P, Kumar N, Rudramurthy SM, Varma N, Varma S. A case ofhistoplasmosis in a patient with MDS/MPN-U. Blood research. 2016 Sep23;51(3):206.
22)   ZamanK, Kaur H, Rudramurthy SM, Singh M, Parashar A, Chakrabarti A. Cutaneousmucormycosis of scalp and eyelids in a child with type I diabetes mellitus.Indian journal of dermatology, venereology and leprology. 2015 May 1;81:275.
23)   SharmaD, Capoor M, Ramesh V, Gupta S, Shivaprakash M, Chakrabarti A. A rare case ofonychomycosis caused by Emericella quadrilineata (Aspergillus tetrazonus).Indian Journal of Medical Microbiology. 2015 Apr 1;33(2):314.
24)   KumaranMS, Bhagwan S, Savio J, Rudramurthy SM, Chakrabarti A, Tirumalae R, Abraham A.Disseminated cutaneous Ochroconis gallopava infection in an immunocompetenthost: an unusual concurrence-a case report and review of cases reported.International Journal of Dermatology. 2015 Mar 1;54(3).
25)   MahajanVK, Sharma V, Prabha N, Thakur K, Sharma NL, Rudramurthy SM, Chauhan PS, MehtaKS, Abhinav C. A rare case of subcutaneous phaeohyphomycosis caused by aRhytidhysteron species: a clinico‐therapeutic experience. International Journalof Dermatology. 2014 Dec;53(12):1485-9.
26)   VinayK, Khullar G, Yadav S, Kanwar AJ, Saikia UN, Shivaprakash MR, Chakrabarti A,Dogra S. Granulomatous invasive aspergillosis of paranasal sinuses masqueradingas actinomycosis and review of published literature. Mycopathologia. 2014Apr;177(3):179-85
27)   VinayK, Chandrasegaran A, Kanwar AJ, Saikia UN, Kaur H, Shivaprakash MR, Dogra S.Primary cutaneous mucormycosis presenting as a giant plaque: uncommonpresentation of a rare mycosis. Mycopathologia. 2014 Aug;178(1):97-101.
28)   KaurH, Rudramurthy SM, Mohindra S, Gupta S, Chakrabarti A. Ochroconis humicolacoexisting with esthesioneuroblastoma: an incidental coloniser or allergen?.Mycopathologia. 2014 Aug;178(1):79-83.
29)   VenkateshwarS, Ambroise MM, Asir GJ, Mudhigeti N, Ramdas A, Authy K, Shivaprakash MR,Kanungo R. A rare case report of subcutaneous phaeohyphomycotic cyst caused byExophiala oligosperma in an immunocompetent host with literature review.Mycopathologia. 2014 Aug;178(1):117-21
30)   SharmaA, Hazarika NK, Barua P, Shivaprakash MR, Chakrabarti A. Acremonium strictum:report of a rare emerging agent of cutaneous hyalohyphomycosis with review ofliteratures. Mycopathologia. 2013 Dec;176(5):435-41.
31)   DuttaP, Premkumar A, Chakrabarti A, Shah VN, Behera A, De D, Rudramurthy SM, BhansaliA. Fusarium falciforme infection of foot in a patient with type 2 diabetesmellitus: a case report and review of the literature. Mycopathologia. 2013Oct;176(3):225-32.
32)   PatelAK, Patel KK, Darji P, Singh R, Shivaprakash MR, Chakrabarti A. Exophiala dermatitidisendocarditis on native aortic valve in a postrenal transplant patient andreview of literature on E. dermatitidis infections. Mycoses. 2013 May 1;56(3).
33)   SinhaM, Shivaprakash MR, Chakrabarti A, Shafiulla M, Babu KG, Jayshree RS.Bacteraemia caused by Sciscionella marina in a lymphoma patient: phenotypicallymimicking Nocardia. Journal of medical microbiology. 2013 Jun;62(6):929-31.
34)   SubbalaxmiMV, Umabala P, Paul R, Chandra N, Raju YS, Rudramurthy SM. A rare presentationof progressive disseminated histoplasmosis in an immunocompetent patient from anon-endemic region. Medical mycology case reports. 2013 Jan 1;2:103-7.
35)   MohammedS, Sinha M, Chavan P, Premalata CS, Shivaprakash MR, Chakrabarti A, JayshreeRS. Oral histoplasmosis masquerading as oral cancer in HIV-infected patient: acase report. Medical mycology case reports. 2012 Jan 1;1(1):85-7.
36)   VermaRK, Shivaprakash MR, Shanker A, Panda NK. Subcutaneous zygomycosis of thecervicotemporal region: Due to Basidiobolus ranaram. Medical mycology case reports.2012 Jan 1;1(1):59-62.
37)   BhattacharyyaS, Shivaprakash MR, Chakrabarti A, Sharma N. Foot bleb infection due torhodotorula mucilaginosa in a diabetic patient: Case report and review of theliterature. Biomed Res. 2012;23(4):577-579.
38)   SinghG, Shivaprakash MR, De D, Gupta P, Gupta S, Kanwar AJ, Chakrabarti A. Chronicdisfiguring facial lesions in an immunocompetent patient due to Exophialaspinifera: a case report and review of literature. Mycopathologia. 2012Oct;174(4):293-9.
39)   ShivaprakashMR, Sumangala B, Prasanna H, Yenigalla BM, Munegowda KC, Ravi D, Chakrabarti A.Nasal vestibulitis due to Nocardiopsis dassonvillei in a diabetic patient.Journal of medical microbiology. 2012 Aug;61(8):1168-73.
40)   XessI, Mohapatra S, Shivaprakash MR, Chakrabarti A, Benny GL, O'Donnell K, PadhyeAA. Evidence implicating Thamnostylum lucknowense as an etiological agent ofrhino-orbital mucormycosis. Journal of clinical microbiology. 2012Apr;50(4):1491-4.
41)   ShivaprakashMR, Singh G, Gupta P, Dhaliwal M, Kanwar AJ, Chakrabarti A. Extensive whitepiedra of the scalp caused by Trichosporon inkin: A case report and review ofliterature. Mycopathologia. 2011 Dec;172(6):481-6.
42)   MinzM, Sharma A, Kumar S, Singh S, Shivaprakash MR, Bag S. Use of autogenousinternal iliac artery for bridging the external iliac artery after excision ofAspergillus mycotic aneurysm in renal transplant recipients. Journal ofvascular surgery. 2011 Mar 1;53(3):802-4.
43)   ShivaprakashMR, Jain N, Gupta S, Baghela A, Gupta A, Chakrabarti A. Allergic fungalrhinosinusitis caused by Neosartorya hiratsukae from India. Medical Mycology.2009 May 1;47(3):317-20.
44)   JanmejaAK, Mohapatra PR, Shivaprakash MR, Khurana A, Aggarwal D. Concurrent infectionof pneumocystis pneumonia and pulmonary tuberculosis in an HIV-seronegativepatient. Indian Journal of Chest Diseases and Allied Sciences. 2008 Oct1;50(4):369-71.
45)   SinghN, Agarwal R, Gupta D, Shivaprakash MR, Chakrabarti A. An unusual case ofmediastinal mass due to Fonsecaea pedrosoi. European Respiratory Journal. 2006Aug 31;28(3):662-4.
46)    Purohit G, Sable M, Rudramurthy SM, Sarkar S, Parida P,Deshmukh V, Hallur V. A rare case of condiobolomycosis due to Conidioboluscoronatus presenting with dysphagia. Indian Journal of Medical Microbiology.2021 Oct 1;39(4):558-60.
47)   CapoorMR, Sen B, Varshney P, Verghese M, Shivaprakash MR, Chakrabarti A.Coccidioidomycosis masquerading as skeletal tuberculosis: an imported case andreview of coccidioidomycosis in India. Tropical doctor. 2014 Jan;44(1):25-8.
48)   SethuramanN, Thirunarayan MA, Gopalakrishnan R, Rudramurthy S, Ramasubramanian V,Parameswaran A. Talaromyces marneffei outside endemic areas in India: anemerging infection with atypical clinical presentations and review of publishedreports from India. Mycopathologia. 2020 Oct;185(5):893-904.
49)    Damaraju V, Agarwal R, Sehgal IS, Khadwal A, Bal A,Rudramurthy SM, Muthu V. Ibrutinib and tracheal mucormycosis: a case report andsystematic review of literature. Journal of Medical Mycology. 2023 Aug1;33(3):101414.
50)   RastogiV, Rudramurthy SM, Maheshwari M, Nirwan PS, Chakrabarti A, Batra S. Non-healingulcer due to Trichosporon loubieri in an immunocompetent host and review ofpublished reports. Mycopathologia. 2013 Aug;176(1):107-11.
51)    Sood R, Peyam S, Saikia UN, Bansal D, Choudhary H,Rudramurthy SM, Radotra BD. Isolated Cerebral Nocardiosis Otitidiscaviarum in aChild with relapsed B-Lymphoblastic Leukemia: Diagnostic and TherapeuticChallenges Including Relevant Review of Literature. Annals of Indian Academy ofNeurology. 2022 Sep 1;25(5):954-7.
52)    Gupta P, Kaur H, Dwivedi S, Agnihotri S, RudramurthySM. First case of Tropicoporus tropicalis keratitis in an immunocompetent hostfrom India and review of the literature. Journal of Medical Mycology. 2022 Mar1;32(1):101205.